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STRUCTURE AND METABOLISM OF SERUM HIGH DENSITY LIPOPROTEINS
CHAPTER I  
INTRODUCTION
The serum or plasma o f a l l  v er te b r a te s  con ta in s a v a r ie ty  o f  
l ip id  compounds which in clud e free  and e s t e r i f ie d  c h o le s te r o l ,  mono-, 
d i - ,  and t r i - g ly c e r id e s ,  n o n e s te r if ie d  or " free"  fa t ty  a c id s , and a 
number o f p h ospholip ids or phosphatides. These l ip id s  per se  are  
e s s e n t ia l ly  w a te r - in so lu b le . In the serum they are bound to  s p e c i f ic  
p ro te in s  and have been d iscr ib ed  as l ip o p r o te in s , which i s  the means by 
 ^ which l ip id s  are g e n e r a lly  s o lu b il iz e d .  By c o r o lla r y , the p ro te in  
m o ie tie s  o f the d if f e r e n t  lip o p r o te in s  a ls o  a c t  as v e h ic le s  for the  
transport o f  l ip id s  in  the serum.
The e a r l i e s t  su gg estio n s regarding the e x is te n c e  o f l ip id -  
p ro te in  a s so c ia t io n s  in  the serum were advanced in  the f i r s t  two decades 
o f th is  century by Nerking ( 1 ) ,  Haslam ( 2 ) ,  Chick ( 3 ) ,  and Bang (4) who 
showed th a t p h ospholip ids and c h o le s te r o l were p resen t in  c e r ta in  sub­
fr a c tio n s  o f e u g lo b u lin . In 1929 Macheboeuf (5) f i r s t  is o la te d  a horse  
serum lip o p r o te in  fr a c t io n  which contained  con stant and c h a r a c te r is t ic  
amounts o f c h o le s te r o l  and p h osp h o lip id s. Subsequently, the serum 
l ip o p r o te in s  o f  other v er teb ra te s  and man were in v e s t ig a te d  by a v a r ie ty  
o f r e l ia b le  techniques in clud ing  s a lt in g -o u t  w ith  ammonium s u lfa t e  ( 5 ,6 ) ,
1
2Cohn fr a c t io n a t io n  ( 7 ) ,  moving boundary ( 8 ) and zone e le c tr o p h o r e s is  
using  paper and sta rch  g e l  (9 ,1 0 ,1 1 ,1 2 ,1 3 ,1 4 ,1 5 ) ,  p r e c ip ita t io n  by h igh  
m olecular substances (1 6 ,1 7 ,1 8 ,1 9 ) ,  immunochemical (2 0 ) , tu rb id im etr ic  
(2 1 ) , u ltr a c e n tr ifu g a l (2 2 ,2 3 ,2 4 ,2 5 ) ,  and chromatographic (26) procedures. 
In p a r tic u la r  the u ltr a c e n tr ifu g a l technique was exceed in g ly  u s e fu l for  
the sep aration  and id e n t i f i c a t io n  o f  serum lip o p r o te in s  (2 7 ,2 8 ,2 9 ,3 0 ,3 1 ,  
3 2 ,3 3 ) .
Serum lip o p r o te in s  were found to  be a heterogeneous group o f  
compounds which d if fe r e d  in  d en sity  and com position  (3 4 ,3 5 ) ,  sedimen­
ta t io n  (3 6 ,3 7 ) ,  and e le c tr o p h o r e tic  m o b ility  (1 0 ) ,
The research  work on serum lip o p r o te in s  su ffered  from i t s  
in ce p tio n  from the lack  o f  a system atized  c la s s i f i c a t io n  and in e v ita b ly  
r e su lte d  in  d if f e r e n t ,  but fo r tu n a te ly  in te r r e la te d , methods o f  c l a s s i ­
f ic a t io n  as shown in  Table I ,  The Committee on L ip id  and L ip op rotein  
Nomenclature o f the American S o c ie ty  for  the Study o f  A th e r o sc le r o s is  
(38) recommended in  1956 th a t lip o p r o te in  fr a c t io n s  be d escribed  according  
to  the method o f sep a ra tio n . T herefore, two major groups cou ld  be 
id e n t if ie d  by d en s ity  g rad ien t s tu d ie s .  Those o f d en sity  l e s s  than
1.063 g per ml comprised the low d en sity  l ip o p r o te in s , w h ile  th ose  o f  
d en s ity  grea ter  than 1.063 g per ml rep resen ted  the h igh  d en sity  l ip o ­
p r o te in s . The former included  se v e r a l su b fra c tio n s , a l l  o f which were 
d is t in c t ly  d if f e r e n t  from the h igh  d en sity  ones in  sev era l ch aracter­
i s t i c s ,  in clud ing  a lower p ro te in  con ten t and a higher c h o le s t e r o l /  
phospholip id  r a t io  (3 9 ,4 0 ) .
The h igh  d en s ity  lip o p r o te in s  are composed o f the alpha l ip o ­
p ro te in s  (QLP, d = 1 .0 6 3 -1 .2 1 0  g per ml) i . e .  HDL2  and HDL3 . L ipo-
TABLE I











E lectro p h o resis
( 1 0 )
Other
(56)
0 .9 6 0 -1 .0 0 6 I  + I I I 20-400 >  70 « 2  or 'o r ig in '  
l ip id
Chylomicrons and 
very low d en sity  LP
1 .006 -1 .019 I  + I I I 1 2 - 2 0 40-70 Pi Low d e n s ity  PLP
1 .0 1 9 -1 .0 6 3 I  + I I I 0 - 1 2 25-40 Pi P L ip op rotein
1 .0 6 3 -1 .1 2 5 IV + V HDLg 20-25 « 1 Oi L ip op rotein  (CKLP)
1 .1 2 5 -1 .2 1 0 IV + V HDL3 1 - 1 0 « 1 0! L ipoprotein  (OLP)
>  1 . 2 1 0 - - -
« 1
Very h igh  d e n s ity  LP 
(VHDLP),
w
4p ro te in s  o f d en sity  greater  than 1 . 2 1 0  g per ml include the very high  
d en sity  lip o p r o te in s  (VHDLP) and lipalbum in, the albumin bound fa t ty  
ac id s (4 1 ) .
The term very h igh  d en sity  lip o p r o te in s  i s  used to  d esig n a te  
lip o p r o te in s  other than lipalbum in which sedim ent a t  105,000 x  g a f te r  
44 hours o f  c e n tr ifu g a tio n  in  a so lv e n t  o f  d en sity  1 .21 g per m l.
A ll  subsequent d isc u ss io n  w i l l  d ea l m ainly w ith  human high  
d en sity  l ip o p r o te in s , u n less  otherw ise s p e c if ie d .
The high d en sity  lip o p r o te in s , exclud ing lipalbum in, have 
an e le c tr o p h o r e tic  m o b ility  s im ila r  to  th a t o f serum g lo b u lin  (4 2 ) ,
S tu d ies by sev era l research ers (4 3 ,4 4 ,4 5 ,4 6 ,4 7 ,4 8 )  u sing  
p r e c ip ita t io n , absorption  and agar d if fu s io n  techniques w ith  h e te r ­
ologous a n tig e n ic  sera , in d ic a te  th a t the h igh  d en sity  lip o p r o te in s  
are immunochemically d is t in c t  from other serum p ro te in s  and p a r t ic ­
u la r ly  from th e ir  lower d en sity  cou n terp arts.
The amount o f h igh  d en sity  lip o p r o te in  reported in  human serum 
v a r ie s  w ith  the methods used w ith  a mean va lu e estim ated  between 250 
and 450 mg per 100 ml serum (3 5 ,4 9 ,5 0 ) .  These rep orts a lso  show 
pronounced sex  d iffe r e n c e s  in  the amounts o f  h igh d en sity  lip o p r o te in s  
which are s ig n if ic a n t ly  h igher in  the fem ale than in  the male a t  every  
age from 17 to  65 y ea rs . The c l in i c a l  importance o f th is  s ig n if ic a n t  
d iffe r e n c e  between sexes i s  not c le a r .
Of the h igh  d en sity  lip o p r o te in s , the alpha lip o p ro te in s  
(QLP) have been e x te n s iv e ly  in v e s t ig a te d . They are so lu b le  in  water 
and e l e c t r o ly t i c  so lu tio n s  (51) and are r e la t iv e ly  more s ta b le  to  
d ia ly s i s  than the low d en s ity  lip o p r o te in s  (5 2 ) .  The m olecular
5w eights range between 165,000 and 450,000 (5 2 ,5 3 ,5 4 ) .  The QLP m olecules  
are assumed to  be e l l ip s o id  in  shape (53) to  account fo r  the in tr in s ic  
v is c o s i t y ,  0 .0 6 6 , and the f r ic t io n a l  r a t io  data . The l a t e s t  c a lc u la ­
t io n s  b y  Vandenheuvel (55) g iv e  a common sh o rt a x is  dim ension o f about 
60 ^ and long a x is  dimensions o f 290 and 171 A, which correspond to  the  
m olecular w eights reported  by Hazelwood (54) as w e ll  as p erm itting  the
l ip id s  to  be packed in  c o r r e c t  proportion  w ith in  a p ro te in  s h e l l  1 0  S.
02th ick  and having a 15.7 A mean area per r e s id u e . These data are n o t  
t o t a l ly  r e l ia b le ,  however, because the a c tu a l geom etric form of the 
QLP i s  u n certa in .
Normally, the h igh  d en s ity  lip o p ro te in s  co n ta in  about 26 and 
47 per ce n t o f the to ta l  serum c h o le s te r o l and p h osp h o lip id s, resp ec­
t iv e ly  w ith  a ch o le ster o l-p h o sp h o lip id  r a t io  o f approxim ately 0 .45  (5 6 ) .  
The per cen t com position o f  serum QLP i s  reported  by Bragdon e t  a l .
(40) as fo llo w s:
%
P rote in  4 6 .4
Tr ig ly c e r  id es  8 .1
Phospholip ids 26 .1
Free C h o lestero l 2 .0
E s te r if ie d  C h o lestero l 17 .4
The OLP have been subdivided  in to  two fr a c t io n s  o f d en sity ,
1 .080 and 1 .15 g per ml (3 6 ) ,  the la t t e r  con ta in in g  a h igher p ro te in  
con ten t (3 4 ,3 9 ) .
There are sm all amounts, i f  any, o f n o n -e s te r if ie d  fa t ty  ac id s  
bound to  OLP. Data on OLP fa t ty  a c id s  are d i f f i c u l t  to  in te r p r e t be­
cause the lengthy procedures fo r  the is o la t io n  and p u r if ic a t io n  o f
OLP, as described  la t e r ,  lead  to  h yd ro ly sis  o f  t r ig ly c e r id e s ,  and,
th e r e fo r e , e lev a ted  v a lu es  fo r  the fa t ty  a c id s .
6The phosphatide com position o f  CüLP i s  s im ila r  to  th a t  o f  whole 
serum except for  a higher percentage o f  ly s o le c i th in  and a lower per­
centage o f sphingom yelin (5 7 ,5 8 ):
Per Cent o f Whole Serum L ip id  P 
Cephalin L e c ith in  L y so le c ith in  Sphingomyelin
Whole Serum 4 .8  68 .2  8 .0  18 .9
The f a t t y  acid  com position  o f  the c h o le s te r o l e s t e r ,  phospho­
l ip id  and g ly c e r id e  m o ie tie s  o f OLP, stu d ied  by g a s - liq u id  chromato­
graphy (5 8 .5 9 ) ,  i s  s im ila r  to  th a t o f  serum and p - lip o p r o te in s . The 
p r in c ip a l f a t t y  a c id s  o f  c h o le s te r o l e s te r s  are l i n o l e i c ,  o le ic  and 
p a lm itic ; those o f  phospholip ids are p a lm it ic , o le ic ,  l i n o l e i c  and 
arach idon ic; and those o f g ly c e r id e s  are o le ic ,  p a lm itic  and l in o ­
l e i c  in  order o f  decreasing  amounts.
The p ro te in  m oiety (CKP) obtained  by d e lip id a t io n  o f OLP w ith  
ethanol and e th er  a t  -25°C was found to  be homogeneous on the b a s is  
of physicochem ical c r i t e r ia  which were app lied  for  i t s  ch a r a c te r iz a ­
tio n  (6 0 ) . There were no id e n t i f ia b le  fr e e  -SH groups or c y s te in e  
(6 0 ,6 1 ) contrary to  the e a r l ie r  fin d in g s  o f  Shore and Shore (62) in  
a study on the amino acid  com position  o f  the same p r o te in . However, 
Scanu and Hughes (63) have found th a t the amino acid  com position  o f 
sev era l su b fra c tio n s  o f CLP was s im ila r  and th is  was c i te d  as support­
ing evidence for  the homogeneity o f the CKP. The carboxyl and amino- 
term inal amino a c id s  o f CLP p ro te in  were shown to  be threon ine and
7a sp a r tic  a c id , r e s p e c t iv e ly  (5 3 ,6 4 ,6 5 ) ,  and were p resen t in  a 1:1 r a t io
assuming a m olecular w eight o f  75,000 for  Q!P.
Moving boundary e le c tr o p h o r e s is  o f the d e lip id iz e d  QLP revea led
the presence o f  one peak w ith  a r a te  o f  m igration  equal to  5.00x10"^
s q .c m ./v . / s e c .  (6 0 ) .
The sed im entation  c o e f f i c i e n t ,  a ls o  reported  by Scanu _et a l .
(6 0 ) , was SgQ ^ 4 .1 1  and the m olecular w eight about 75 ,000 . R ecen tly ,
Shore and Shore ( 6 6 ) obtained a subunit o f OP by the a d d itio n  o f 0.08%
sodium dodecyl s u lfa te  to  the p ro te in  s o lu t io n . The sed im entation
c o e f f i c ie n t  o f  the subunit was s<,« 2 .3  to  2 .6  w ith  a m olecularzu,w
w eight o f 38 ,000  + 1000. On the b a s is  o f the la t t e r  w eigh t, one mole 
o f am ino-term inal a sp a r tic  ac id  was p resen t per mole Off. In view  of  
th ese  f in d in g s  Shore and Shore suggested  th a t Scanu e t  (60) had 
i s o la te d  a dimer form o f the p r o te in .
The Off con ta in s about 0 .5  per cen t hexose in  the form of 
g a la c to se  and mannose, and 0 .3 5  per cen t hexosamine as glucosam ine on 
dry w eigh t b a s is  (6 0 ) .
The recom bination o f l ip id - f r e e  p ro te in  w ith  l ip id s  v it r o  
(67) and j u  v iv o  ( 6 8 ) shows th a t Off r e ta in s  i t s  fu n c tio n a l cap acity  
to  bind l i p i d s .  Furthermore, the b io lo g ic a l  h a lf - t im e  o f the p ro te in ,  
la b e led  w ith  I^^l which i s  about 4 days, i s  s im ila r  to  in ta c t  QLP 
(4 5 ,6 3 ,6 9 ) .  The serum OLP o f dog ( 6 8 ) and ra b b it  (70) a ls o  have sh ort  
h a lf - t im e s .
The Off i s  a ls o  capable o f recom bination w ith  chylom icrons 
in  v i t r o  (6 7 ) . The data on the carboxyl and am ino-term inal amino 
a c id s  (5 3 ,6 4 ) ,  f in g erp r in tin g  (7 1 ,7 2 ) ,  son ic  o s c i l la t io n  experim ents
8(73) and exchange o f I^^^-labeled  chylom icron p ro te in  v i t r o  (74) 
in d ic a te  th a t one o f the p ro te in s  p resen t in  the chylomicrons has the 
same c h a r a c te r is t ic s  as th a t o f  the COJP p ro te in .
The CULP phospholip ids exchange f r e e ly  w ith  lower d en s ity  l ip o ­
p ro te in s  (7 5 ,7 6 ,7 7 ,7 8 ) .  On the other hand, in  v i t r o  (79) and in  v iv o  
(80) s tu d ie s  in d ica te  th a t  fr e e  c h o le s te r o l in  serum, chylom icra and 
red blood corp u scles i s  r e a d ily  exchangeable, w ith  p a r t ia l e q u ilib r a ­
t io n  occurring w ith in  m inutes. Turnover s tu d ie s  which in vo lve  QLP 
w ith  la b e led  c h o le s te r o l or ph osp h olip id , th ere fo re , have n o t been  
popular because o f th ese  fa c ts  which render m etab olic  in te r p r e ta tio n s  
dubious.
The sy n th e s is  o f  QLP by r a t - l iv e r  s l i c e s  (81) and perfused  
r a t  l iv e r  (82) has been dem onstrated, and the r a te  o f  sy n th es is  o f  the  
p ro te in  i s  independent o f c h o le s te r o l sy n th e s is  (8 2 ) .  No data i s  
a v a ila b le  on the sy n th e s is  o f lip o p r o te in  by t is s u e s  other than the  
l iv e r  although the sm all in t e s t in e  i s  thought to  be an a c t iv e  s i t e  for  
QP b io sy n th e s is  (7 2 ) .
In v iv o  s tu d ie s  (69) in d ic a te  th a t the p ro te in  m o ie tie s  o f  high  
and low d en s ity  lip o p r o te in s  are m eta b o lica lly  d is t in c t  which i s  con­
trary  to  the in te r r e la t io n s h ip s  between exchangeable l ip id  ccmponents.
as described  e a r l ie r .
;
The serum le v e ls  o f QLP aré^decreased in  primary or secondary  
hyperlip idém ie d isea se  s ta te s  (56) and by n u tr it io n a l and hormonal 
fa c to r s  (8 3 ) .  There i s  no ev idence, however, th a t decreased serum 
QLP le v e l  per se  i s  harm ful.
The very h igh  d en s ity  lip o p r o te in s  (VHDLP) have not been
9is o la te d  y e t  as a chem ical e n t i t y .  The 1 .210 in fran atan t o f human 
serum contains 8-15% of the t o t a l  serum l ip id  phosphorus but e s s e n t ia l ­
ly  no c h o le s te r o l (3 4 ,3 5 ,4 0 ,5 6 ,8 4 ) .  In the dog, ch icken , ra b b it  and 
r a t ,  the VHDLP con ta in  7, 9 , 23 and 27-40% o f the to ta l  serum phospho­
l ip id s  w ith  no c h o le s te r o l (3 4 ,8 5 ) .  Turner ^  a l .  ( 8 6 )  have demon­
s tr a te d  the presence o f a p h osp h o lip id -p ro te in  complex, fr e e  o f  ch o l­
e s t e r o l  and accounting for  about 60% o f the t o t a l  serum p h osp h o lip id s. 
They have reported  th a t , fo llo w in g  the intravenous a d m in istra tion  of
O  O
P to  human su b je c ts , the s p e c i f ic  a c t iv i t y  i s  most pronounced in  
the p h osp h o lip id -p ro te in  complex (8 7 );  th is  complex was never is o la te d  
and p u r if ie d .
The VHDLP were la te r  described  as a phosphorus-containing pep­
t id e  (4 0 ,8 4 ,8 8 ) . Kunkel and Trautman (4 2 ) , who co rr e la ted  the u lt r a ­
c e n tr ifu g a l and e le c tr o p h o r e tic  p ro p ertie s  o f  human serum lip o p r o te in s  
by using  starch  block  or a p o ly v in y lr e s in  (Geon 400x65), showed th a t  
the VHDLP are n ot s p e c i f i c a l ly  separated from CULP by e le c tr o p h o r e s is .  
P h il l ip s  (89) showed by a s i l i c i c  ac id  column chromatographic tech ­
nique th at the VHDLP con ta in  phosphatides w ith  the fo llo w in g  d i s t r i ­
bution:





L ec ith in  25
L y so le c ith in  56
The ly s o le c i th in  in  the VHDLP accounts for  about 50 per cen t  
of the to ta l  serum ly s o le c i t h in  (8 9 ) .
As y e t ,  no m etabolic r o le  can be ascrib ed  to  the VHDLP,
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The purpose o f  th is  d is s e r ta t io n  i s  tw o-fo ld :
(A) Chemical and P hysico-chem ical S tu d ies o f Human and Horse
QLP;
1. To compare the physico-chem ical c h a r a c te r is t ic s  o f  human 
and horse serum l ip id s  and CUP;
2 . to  e lu c id a te  the behavior o f  OLP p ro te in  in  e l e c t r o ly t i c  
so lu tio n s  con ta in in g  urea, sodium dodecyl s u lf a t e  or s u c c in ic  anhydride 
w ith  regard to  a s s o c ia t io n -d is s o c ia t io n  phenomena; and,
3 . to  id e n t ify  the p ro te in  m oiety o f  VHDLP;
(B) Recombination and M etabolic Study;
1 . To dem onstrate in  v i t r o  recom bination o f CKP ü ith  serum
lip id s  under a v a r ie ty  o f  co n d itio n s  ;
2 . to  study the tim e course o f the plasma r a d io a c t iv ity
131fo llo w in g  the in je c t io n  o f I  - la b e le d  OLP or CXP in  normal human 
su b jec ts  and p a t ie n ts  w ith  hyperlip idem ia; and,
3 . to  show the e x c r e tio n  o f I^ ^ ^ -labeled  QLP in  the u rin e  
of a p a t ie n t  w ith  the n ep h rotic  syndrome, fo llo w in g  the intravenous  
ad m in istra tion  of la b e led  QLP.
CHAPTER I I  
MATERIALS, SUBJECTS, AND METHODS
M ateria ls  
Human Serum or Plasma
Venous blood was obtained from the a n t ic u b ita l  v e in s  o f young 
and apparently h ea lth y  fa s t in g  male and fem ale in d iv id u a ls  who were 
e ith e r  m edical stud en ts or employees o f the U n iv ers ity  o f Oklahoma 
M edical Center.
To obtain  plasma, blood was c o l le c te d  in  p la s t ic  con ta in ers  
(P liap ak , Panheparin 2115, Abbott) w ith  heparin  sodium as the a n t i ­
coagu lan t. Plasma was then separated and processed  w ith in  two hours 
a f te r  the venipuncture.
Serum was a ls o  obtained from blood c o l le c te d  from fa s t in g  in ­
d iv id u a ls  and allowed to  c l o t  in  evacuated empty plasma con ta in ers  
(A b b ott). Sera from se v e r a l donors o f the same sex  were pooled in  
batches o f 300 to  600 ml p r io r  to  u ltr a c e n tr ifu g a t io n .
Horse Serum
Blood was obtained from the jugular v e in s  o f 18 normal fem ale 
Shetland ponies belonging to  Mr. H.O. Pope and from an American saddle- 




The blood was c o l le c te d  in  empty, plasma con ta in ers (Abbott) 
by lo c a l  D.V.M. Drs. T.G. Sew ell o f G uthrie, Oklahoma, and J.M. Brown 
o f Oklahoma C ity .
Trypsin (Pancreas)
Grade A, a c t iv i t y  6 .0  u n its  per mg (K unitz) was purchased 
from C.F. Boehringer & Soehne, Gmbtt, Manheim.
CK-Ghymotrypsin (Bovine Pancreas)
Grade A, c r y s t a l l in e ,  s a l t - f r e e ,  a c t iv i t y  7 .8  u n its  per mg 
(Wu & Laskowski) was purchased from C.F, Boehringer & Soehne,
Gmbtt, Manheim.
and lo r e s in
131Both s t e r i l e  sodium ra d io -io d id e  (1  ) s o lu t io n  and the anion
exchange r e s in , lo r e s in ,  were purchased from Abbott L aboratories, Oak 
R idge, Tennessee, U .S.A .
Subjects
Three, h ea lth y , male vo lu n teers w ith  normal serum l ip id  le v e ls  
were u t i l i z e d  as co n tro l su b je c ts . Their ages ranged between 26 and 
56 y ea rs . Subject P.G. had id io p a th ic  e p ile p sy  s in ce  childhood but 
w e ll c o n tro lled  w ith  d i la n t in  and p h énobarb ita l.
S ix  p a t ie n ts ,  four w ith  primary hyperglyceridem ia, one w ith  
id io p a th ic  fa m ilia l h yp erch olestero lem ia , and one w ith  hyperlip idem ia  
of nephrosis a sso c ia ted  w ith  subacute g lom eru lon ep h ritis , ranging in  
age from 14 to  65 y e a r s , were stu d ied . Subjects S.H. and H,H, were 
s ib l in g s  w ith  fa m il ia l  hyperchylomicronemia, heparin-unresponsive and
13
fa t-a ccen tu a ted  hyperglyceridem ia w ith  l i t t l e  or no hypercholestero lem ia  
or hyperphospholipidem ia (9 0 ,9 1 ,9 2 ) .  Hepatosplenomegaly was p resen t and 
a h is to r y  was obtained o f  "abdominal c r ise s"  in  both su b je c ts , but there  
were no xanthomata, xantholasm ata or arcus s e n i l i s .  Subjects O.C. and 
O.W. had a d ietary  carbohydrate-accentuated and h ep arin -resp on sive (91 , 
92) hyperglyceridem ia w ith  evidence o f o ld  cerebrovascu lar a cc id en ts  
and roen tgen o log ic  ev idence o f  c a lc i f ic a t io n  o f the abdominal a o r ta .
The p a t ie n t  w ith  id io p a th ic  h yp erch o lestero lem ia , J .C .,  had xanthomata 
and xantholasm ata but no arcus s e n i l i s .  F in a l ly ,  the p a t ie n t  w ith  the 
n ep h rotic  syndrome, M .S ., was h o sp ita liz e d  a t  the C h ild ren 's Memorial 
H o sp ita l, Oklahoma C ity , w ith  the c la s s ic a l  symptoms and s ig n s  o f  
n ep h rotic  syndrome. The kidney b iopsy from th is  p a tie n t  a ls o  showed 
fin d in g s  o f subacute g lom eru lo n ep h r itis . Of th ese  6  p a t ie n ts ,  S.H . and 
M.S. were the only fem ale in d iv id u a ls .
Methods
I s o la t io n  and P u r if ic a t io n  o f  CULP 
The is o la t io n  procedure, a m o d ifica tio n  o f the methods o f  
Gofman e t  a l .  (93) and Lewis e t  a l .  (3 3 ) , i s  d ep icted  in  F igure I .
Fresh serum was su bjected  to  u ltr a c e n tr ifu g a t io n  in  Spinco c e l lu lo s e  
tubes (1 /2  X 3 1/2 in ) ,  a t  0°C, in  the No. 40 ro to rs  of three Model 
L Spinco or Beckman u ltr a c e n tr ifu g e s . The chylom icrons and very  low  
d en s ity  lip o p ro te in s  were separated a t  35 ,000 x  g fo r  20 m inutes.
This s tep  could be om itted when the procedure was app lied  only fo r  the 
i s o la t io n  o f QLP, The d en s ity  was then ad ju sted  to  1.063 g per ml 
w ith  NaCl and lip o p r o te in s  o f  d en sity  l e s s  than 1.063 g per ml were
Figure 1 - Isolation and Purification of QLP
Serum or 
Plasma
C entrifuge 20 min. a t  35 ,000  xg 
1
Chylomicrons 
and very low 
d en s ity  lip o p r o te in s
C hylom icron-free fr a c t io n
1 ) A djust d en sity  to  1.063  
g/m l w ith  NaCl
2) C entrifuge 22 hrs a t
105,000 xg
PLP Chylomicron-pLP-free fr a c t io n
1) A djust d e n s ity  to
1 .210  g/m l w ith  KBr
2) C entrifuge 44 hrs a t
105,000 xg
OLP w ith  albumin VHDLP and 
plasma p ro te in s
1) Wash 2-3 X w ith  1 .210 d en sity  
NaCl-KBr and 0.01% EDTA
2) C entrifuge 44 hrs each time 
a t  105,000 xg
P u r if ie d  QLP Washings con ta in in g  
albumin and some QLP
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separated  a t  105,000 x  g for  22 or 17 hours. The so lv e n t  d en sity  was 
in creased  to  1.210 g per ml w ith  potassium  bromide and the OLP separa­
ted  a t  105,000 X g for  44 hours. The QLP were p u r if ie d  2 or 3 times 
to  remove traces o f  albumin by washing w ith  1 . 2 1 0  d en sity  sodium 
ch lor id e-p o tassiu m  bromide so lu tio n  con ta in in g  0.01% EDTA and r e c e n tr i­
fuging a f te r  each wash for  2 2  or 44 hours.
In a l l  fr a c t io n s  c e n tr ifu g a tio n  r e su lte d  in  the f lo t a t io n  o f  
l ip o p r o te in s  (supernatant) o f  d en sity  l e s s  than the medium, w h ile  
lip o p r o te in s  o f d en s ity  grea ter  than the so lv e n t  sedimented to  the 
bottom (in fra n a ta n t) w ith  a c o lo r le s s  zone rem aining in  between. The 
supernatant fr a c t io n  was separated from the in fra n a ta n t by s l i c in g  in  
the cen ter  o f  the c le a r  zone using a Spinco tube s l i c e r .  The very h igh  
d en sity  lip o p r o te in s  sedim ented along w ith  a l l  serum p ro te in s  in  the
1 . 2 1 0  in fra n a ta n t fr a c t io n .
D e lip id a tio n  of QLP
The u ltr a c e n tr ifu g a lly  separated and p u r if ie d  OLP s o lu t io n  was 
d ia ly zed  a g a in s t  0 .1 5  M sodium ch lor id e  s o lu t io n  a t  1°C for two days 
w ith  changes of the NaCl s o lu t io n  tw ice d a i ly .  Subsequently, l ip id  
e x tr a c t io n  was performed according to  the method described  by Scanu, 
Lewis and Bumpus (65) in  a co ld  chamber a t  -30°C . One p art o f  QLP 
s o lu t io n  was tran sferred  in to  a f la s k  con ta in in g  30 p arts o f r e d i s t i l l e d  
eth an ol and p ero x id e -fr ee  eth er (3 :1  v /v )  p rev io u sly  cooled  to  -30°C, 
G entle shaking performed a t  15-minute in te r v a ls  fo r  2 to  3 hours was 
fo llow ed  by f i l t r a t i o n  (Whatman F i l t e r  Paper 41H) o f the m a ter ia l in  
the same chamber and washing the p r e c ip ita te  w ith  p ero x id e -fr ee  ether
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Ihe f i l t e r  paper w ith  the p ro te in  p r e c ip ita te  was tra n sferred  next to  
a m od ified  S oxh let apparatus th at provided continuous e x tr a c tio n  o f any 
rem aining l ip id  a t  -30°C , for  24 hours, w ith  p ero x id e -fr ee  eth er as the 
s o lv e n t . The p ro te in  remaining on the f i l t e r  paper was p laced  over 
D r ie r ite  in  an evacuated d ess ica to r  for  6  hours a t  room temperature 
and then stored  in  the r e fr ig e r a to r .
The a lc o h o l-e th e r  and ether e x tr a c ts  were evaporated to  dry­
n ess and the l ip id s  and p ro te in  (none p resen t) con ten ts determ ined.
A sample o f  the dry, d e lip id iz e d  OOJB was analyzed fo r  n itrogen  
con ten t by the K jeldah l method (94) and fo r  any remaining l ip id  which 
could be ex tra c ted  w ith  B lo o r 's  e th a n o l-d ie th y l eth er (3 :1  v /v ) .
The p ro te in  v a lu es  were c a lc u la te d  by m u ltip ly in g  the n itrogen  
v a lu es  by a fa c to r  o f 6 .2 5 .
L ip id  and L ipoprotein  D eterm inations
T otal and fr e e  c h o le s te r o l were determined by the method o f  
Schoenheimer and Sperry (9 5 ) ,  l ip id  phosphorus by the method of F iske  
and Subbarow (9 6 ) , t r ig ly c e r id e s  by the method o f Van Handel and 
Z ilv ersm it (97) and n o n -e s te r if ie d  fa t ty  a c id s  by the method o f Dole 
(9 8 ) .
Four c la s s e s  o f  l ip o p r o te in s , namely, < 1 .006 , 1 .0 0 6 -1 .0 1 9 , 
1 .0 1 9 -1 .0 6 3  and >1.063 g per ml, were p a r tit io n e d  by u ltr a c e n tr ifu g a ­
t io n  by a m o d ific a tio n  (99) o f the method o f H avel, Eder and Bragdon 
(3 5 ) .  The samples were adjusted  to  d e n s it ie s  o f  1 .006 , 1.019 and
1.063 g per ml u sing  sodium s u lfa te  s o lu t io n s  o f  varying d e n s it ie s  and 
subsequently  cen tr ifu g ed  in  p o lyeth elen e  tubes (1 /2  x 3 1 /2  in ) a t
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105,000 X g and 0°C fo r  22 hours in  No. 40 ro tor  o f the Model L Spinco  
or Beckman u ltr a c e n tr ifu g e s . The tubes were su bjected  n ex t to  quick  
freez in g  a t  -70°C in  a dry ic e -a ce to n e  bath and sawed in  the m iddle o f  
the c o lo r le s s  zone in to  supernatant and in fra n a ta n t fr a c t io n s  using  a 
self-pow ered  jig -sa w  (S ea rs , Roebuck and C o .) . The two fr a c t io n s  were 
mixed w ith  isop rop an ol, made up to  a standard volume and f i l t e r e d .
The t o t a l  c h o le s te r o l was determined by the au to-analyzer u sing  the 
procedure o f Z la tk is , Zak and Boyle (100) and the l ip id  phosphorus de­
termined according to  foregoing  method (9 6 ) .
Phosphatide A nalysis by S i l i c i c  
Acid Chromatography
For the l ip id  e x tr a c tio n , one volhme o f whole serum or QLP 
was ex tra c ted  w ith  twenty volumes o f r e d i s t i l l e d  chloroform -methanol 
(1 :1  v /v )  according to  a m o d ifica tio n  o f  the Sperry procedure (1 0 1 ).
The method o f M arin etti and h is  a s so c ia te s  (102) was used for  
s i l i c i c  a c id  column and s i l i c i c  ac id  impregnated paper chromatography. 
The s i l i c i c  ac id  (M allinckrodt AR, 100-250 mesh) was standardized  
according to  the procedure by Horning ^  (103) and contained  le s s
than 10% m oisture. A sample con ta in in g  approxim ately 500-750 ug o f  
l ip id  phosphorus was ap p lied  onto a 10-gram column (2 .5  cm d iam eter). 
N eutral l ip id s  were f i r s t  e lu ted  w ith  chloroform . The phospholip ids  
were n ex t e lu ted  in  four fr a c t io n s , u sin g  about 125 ml o f  each o f  20%, 
30% and 50% methanol in  chloroform  and f in a l l y  ab so lu te  m ethanol. The 
l ip id  phosphorus in  the fr a c t io n s  was analyzed; the r ec o v er ie s  were 
over 90%. Samples were ap p lied  in  t r ip l i c a t e s  and the paper developed  
w ith  d iiso b u ty lk e to n e :a c e t ic  acid:w ater (4 0 :2 5 :5 ) a t  20°C for  about 18
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hours. Hie papers were then d ried ; one s e c t io n  o f  the s t r ip  o f paper 
s ta in ed  w ith  Rhodamine 6 G and corresponding sp o ts  analyzed for phos­
phorus (1 0 4 ) . Hie r e s u lt s  o f  phosphatide an a ly ses  were reported  as 
per cen t o f t o t a l  phosphorus e lu ted  from the column.
L abeling o f QLP and QT 
A m o d ifica tio n  (105) o f the method o f  B ou rsn ell e t  a l .  (106) 
was used for la b e lin g  OLP and CüP (d e lip id iz e d  CLP). Hie ra d io -  
io d in a ted  p ro te in  was passed  tw ice through an anion  exchange r e s in ,  
lo r e s in  (A bbott), to  remove the fr e e  io d in e . The number o f io d in e
atoms per p ro te in  m olecule varied  between 1:1  and 3:1  (105) w ith  a
131con cen tra tion  o f 3 mg p r o te in  and 10 to  25 uc o f  I  per m l.
T 31 131The la b e led  p ^ - I  and CKP-I were checked by agar and
sta rch  g e l  e le c tr o p h o r e s is , as described  below , and showed the same 
m o b il i t ie s  as th e ir  u n lab eled  cou n terp arts . When the p ro te in  m oiety  
was p r e c ip ita te d  q u a n t ita t iv e ly  w ith  50 per c e n t  tr ic h lo r o a c e t ic  a c id ,  
more than 95% o f the t o t a l  r a d io a c t iv ity  was recovered in  the p r e c ip i­
t a t e .  Scanu and Hughes (72) reported  th a t 5 to  8  per cen t o f  th e t o t a l
131a c t iv i t y  was in  the l ip id  m oiety o f CLP-I
In V itro  Recombination S tu d ies
131A tracer  amount o f  the la b e led  0 !P-I was incubated w ith  th ree  
5  ml sera  o f  normal or hyperlip idém ie human su b jec ts  and o f  horse fo r  
30 m inutes a t  20°C in  th ree Spinco c e l lu lo s e  tu b es. The d e n s it ie s  o f  
the samples were ad ju sted  to  1 .006 , 1.063 and 1 .21  g per ml by the ad­
d it io n  o f s o l id  NaCl-KBr fo llow ed  by u ltr a c e n tr ifu g a t io n  a t  105,000 x  g 
fo r  22 hours, as d escrib ed  e a r l ie r .  The supernatant and in fra n a ta n t
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fr a c t io n s  were separated  by s l ic in g  the tubes and th e ir  r a d io a c t iv ity  
determined in  a w e ll- ty p e , c r y s ta l  s c i n t i l l a t i o n  counter ( s e e  below ).
In Vivo Recombination and Turnover Studies
To block th y ro id a l uptake o f r a d io io d in e , a l l  su b jec ts  in  th is  
study rece ived  L ugol's s o lu t io n , 30 drops d a ily  s ta r t in g  2 days prior  
to  OlLP-I^^^ or in je c t io n  and continued  throughout the study
p eriod .
Approximately 25 *ic o f  CKLP-I^^  ^ or was adm inistered
in traven ou sly  to  each su b jec t  a f te r  an overn ight f a s t  and a f te r  30 
m inutes blood was obtained in  heparin ized  sy r in g e s . Subsequently, 
blood samples were obtained a t  2 4 -h o u r-in terv a ls  for  8-10 days.
S ix  su b jec ts  were g iven  during the study period a la rg e  fa t ty  
m eal. Two and o n e -h a lf hours la t e r ,  a p ost-p ra n d ia l blood sample was 
obtained , fo llow ed  by an in je c t io n  o f 1 0 0  mg o f heparin sodium in tr a ­
m uscularly , and h a lf  an hour la te r  a second blood sample was c o l le c t e d .  
In both occasions blood was obtained fo r  n o n -e s te r if ie d  f a t t y  a c id s  as 
w e ll ,  w ith  EDTA as the a n tico a g u la n t, and th e samples were im m ediately  
ic e d  to  prevent in  v i t r o  h y d ro ly sis  o f  t r ig ly c e r id e s .
Plasma was separated  le s s  than one hour a f te r  the blood was 
obtained . From each sample o f  b lood , a 5 ml a liq u o t  was counted in  
a g la s s  v ia l  for t o t a l  r a d io a c t iv ity  w h ile  3 other a liq u o ts  were sub­
je c te d  to  u ltr a c e n tr ifu g a t io n  a t  3 d if f e r e n t  d e n s it ie s  as d escribed  
under the in  v i t r o  recom bination s tu d ie s .  The supernatant and in fr a -  
natan t fr a c t io n s  were s im ila r ly  separated  and counted for  r a d io a c t iv ity .
The l l3 1  a c t iv i t y  o f  a l l  serum samples were recorded i n i t i a l l y
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and a t  the con clu sion  o f the study in  a w e ll- ty p e  sodium iod id e-p h th a-  
la t e  c r y s ta l  s c in t i l l a t io n  counter (P icker) w ith  an e f f ic ie n c y  of  
52 per cen t and a background o f 120-140 counts per m inute. An 
standard w ith  the same volume was a ls o  counted d a ily  to  d e te c t  v a r ia ­
t io n s  in  counter s e n s i t iv i t y .
Twenty-four-hour urine c o l le c t io n s  were obtained and 10 ml 
a liq u o ts  counted for  r a d io a c t iv ity .
Amino Acid A nalysis  
The p ro te in  m oiety was dried  to  co n sta n t w eigh t ^  vacuo over 
P2 O5 . The con d itio n s for  ac id  h y d ro ly s is  were co n stan t b o ilin g  hydro­
c h lo r ic  a c id  (1000 volumes) in  an evacuated tube a t  110°C for  20 hours. 
The tryptophane determ ination was performed a f te r  h y d ro ly s is  w ith  3 .5  N 
barrium hydroxide (1000 volumes) in  an evacuated tube a t  100°C for 10 
hours. The con d ition s for  amide n itrogen  h y d ro ly s is  were 1 N su lfu r ic  
ac id  (1000 volumes) a t  atm ospheric pressure and 100°C for  3 hours.
The chromatographic a n a ly s is  o f the amino a c id s , as w e ll as the  
phosphorus con ten t o f the p r o te in , were determined by A n aly tic  Corpo­
r a t io n  (New Y ork).
Enzymatic H ydrolysis o f P ro te in  
The primary stru ctu res  o f the human and horse 0 !P were compared 
by tr y p t ic  and chym otryptic h y d ro ly s is  (107) and the p ep tid es separated  
by tw o-dim ensional chromatography and h igh  v o lta g e  e le c tr o p h o r e s is  (108), 
The p ro te in  was d isso lv ed  in  6  M urea and 0 .3  M ammonium carb­
onate b u ffer  (pH 8 .4 ) ,  d ilu te d  w ith  d i s t i l l e d  w ater, 1 :1 .5  v /v ,  and 
k ep t in  a h ot water bath for 15 m inutes, then coo led  to  room temperature.
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One drop of phenol red and an aqueous so lu tio n  o f try p sin  ( r a t io  tr y p s in / 
p ro te in  1:30) were added. The m ixture was incubated in  a w ater bath a t  
28°C for  1 .5  hours. Subsequently, the same amount o f chymotrypsin was 
added and the m ixture trea ted  s im ila r ly . The h yd rolysate was tran sferred  
to  a 1 X 6 cm Dowex 50W-X2 (Baker, ch lo r id e  s a l t ,  100-200 mesh) column. 
Urea was removed w ith  200 ml o f  w ater. The p ep tid es were e lu ted  w ith 4M 
ammonium hydroxide, ly o p h iliz e d  overn igh t, r ed isso lv e d  in  w ater, and 
app lied  on Whatman No. 3 papers. The chromatograms were developed w ith  
the upper phase o f a m ixture o f normal b u ta n o l:a c e tic  acid :w ater (4 :1 :5 )  
for about 7 hours and dried  overn ight a t  room tem perature. The second  
dimension was developed by e le c tr o p h o r e s is  w ith  a c e t ic  a c id :p y r id in e:  
water (10 :1 :8 9 ) a t  2000 v o lt s  (215 mA.) for  50 m inutes. The sp o ts  were 
developed w ith  a 0.5% m ethanolic ninhydrin so lu tio n  and heated for  10 
minutes a t  80°C.
Terminal Amino Acid Determ ination  
The d in itro flu orob en zen e (DNFB) method was used (1 0 9 ) . To 1 
volume o f p ro te in  (2 .5  mg) so lu t io n  con ta in in g  2% sodium b icarbonate,
2 volumes o f 2.5% DNFB in  ethanol were added and the s o lu t io n  allow ed  
to  stand a t  room temperature for 2 hours. The pH was ad justed  to  2 w ith  
0 .1  N HGl, the m ixture ex tracted  w ith  p ero x id e -free  e th e r , and the  
d in itro p h en o l-p ro te in  dried  in  a d e ss ic a to r  over ^2^5* d in itr o -
p h en o l-p rotein  was hydrolyzed w ith  7 .5  N r e d i s t i l l e d  HCl for  24 hours 
under r e f lu x , d ilu te d  w ith  water and ex tracted  four tim es w ith  5 ml 
p ortions o f p ero x id e -free  e th er . The ether e x tr a c ts  were combined, the 
so lv e n t was removed iji vacuo, and the resid u e tra n sferred  q u a n tita t iv e ly
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to  the paper w ith  a ceton e. Chromatograms were developed w ith  t e r t ia r y  
amyl a lc o h o l saturated  w ith  0 .0 5  M potassium  acid  p h th a la te  (pH 5 .9 )  for  
12 hours. A fter  drying the paper, the DNP-amino a c id  sp o ts  were e lu ted  
w ith  4 ml o f 1% sodium b icarbonate so lu t io n  and the o p t ic a l  d en sity  
determined in  a Beckman DU spectrophotom eter a t  360 mu. A known sample 
o f a ch em ica lly  pure DNP-amino a c id  (th e  same as th a t found in  CüP) was 
used sim ultaneously  to  co r r e c t  for  lo s s e s  due to  the procedure.
Starch Gel E lectro p h o resis  
The g e l  was processed  according to  the procedure o f  Sm ithies 
(110) u sin g  hydrolyzed sta rch  (Connaught) p laced in  f ib e r  g la s s  molds 
(1  X 14 X 15 cm) and l e f t  stand ing overn ight b efore  u se . A cu t was made 
in  the g e l  a t  a d ista n ce  o f 3 cm from the cathode end. Samples for  
e le c tr o p h o r e s is  were ap p lied  on sm all p ie c e s  o f f i l t e r  paper (Whatman 
No. 1) and placed in  the s l i t .  E lectro p h o resis  was performed a t  a 
p o te n t ia l  grad ien t o f 6 v o lt s  per cm a t  room tem perature u sin g  a H eathkit 
power supp ly . Subsequently, the g e l  was sec tio n ed  in to  two la y ers  to  
a llow  fo r  a separate s ta in in g  w ith  Amido Black B for p r o te in  and O il Red 
0 for  l i p i d .  When r a d io a c tiv e  m ater ia l was checked by e le c tr o p h o r e s is ,  
the s ta in ed  s e c t io n  was s l ic e d  in  equal p ie c e s  and r a d io a c t iv ity  measured 
in  a w e ll- ty p e  c r y s ta l  s c i n t i l l a t i o n  counter.
Agar Gel E lectro p h o resis  and 
Immunoelec tr  ophores i s
The technique o f Grabar and W illiam s (111) was u sed . A 1 per
cen t agar (D ifco ) so lu t io n  in  a sodium veronal b u ffer  (pH 8 .6 )  was
spread even ly  over dry g la s s  p la te s  (10 x  8 cm) p re trea ted  w ith  ethanol
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to  render them f a t - f r e e .  S l i t s  ( 1 x 3  mm) were c u t for  the a p p lic a tio n  
of samples 1 cm from the cathode end. E lectro p h o resis  was performed in  
4 to  6 hours a t  6 v o lt s  per cm and 10 m illiam p eres . Ihe g e l  was s ta in ed  
w ith Amido Black B or O il Red 0 . For the im m unoprecipitin study, a 
trough (3 X 60 mm) was cu t perpendicular to  the o r ig in a l s l i t  a t  a 
d ista n ce  o f 5 mm and f i l l e d  w ith  horse anti-norm al human serum (Immun­
o logy , I n c . ,  C hicago).
D eterm ination o f Sedim entation C o e ff ic ie n ts  
The equation  o f D egeles and Gutter (112) was used to  determine 
the apparent sed im entation  c o e f f i c ie n t  (®app.):
2.303 (d lo g  X /  dt)
Sapp,
60 (0^2 ) (1) 
where x i s  the d ista n ce  o f the boundary from the cen ter  o f the r o ta t io n  
a t  tim e t  ( in  seco n d s), and OJ i s  the angular v e lo c ity  o f c e n tr ifu g a tio n .
The sc h lie r e n  p a ttern  was developed on p h otop la tes (Eastman 
Kodak) a u tom atica lly  in  the Spinco Model E u ltr a c e n tr ifu g e  a t  8 or 16 
minute in t e r v a ls .  A m icro-comparator g iv in g  an accuracy o f  1 x 10”^ cm 
was used to  determine the p o s it io n  o f  sedim enting boundaries. The d lo g  
X /  d t was obtained by p lo t t in g  d log  x versus t .
The S20jW (sed im en tation  c o e f f i c ie n t  under standard co n d ition s  
of 20°C and water as so lv e n t)  was obtained from s^pp^ using  the  
Svedberg and Pedersen equation  (1 1 3 ).
CHAPTER III
RESULTS
I so la t io n  and P u r if ic a t io n  o f OLP
The sera  or plasma o f fa s t in g  h ea lth y  human donors and horses 
were analyzed for  t o t a l  l ip id s ;  the r e s u lt s  are presented  in  Table I I .  
The ages o f the male and fem ale su b jec ts  ranged between 22 and 35 y ears , 
and the t o t a l  c h o le s te r o l,  phospholip id  and g ly c e r id e  serum le v e ls  f e l l  
w ith in  the normal range.
H alf o f the mares were pregnant, but there were no s ig n if ic a n t  
d iffe r e n c e s  in  the serum l ip id s  or lip o p r o te in  p attern s between the 
pregnant and non-pregnant mares. The t o t a l  serum c h o le s te r o l le v e l  for  
horses was below 100 mg per 100 ml and the t o t a l  serum l ip id s  (tw o- 
th ird s  to  th ree-fo u rth s o f which were OLP) averaged about 290 mg per 100 
ml corresponding to  approxim ately h a lf  the average l ip id  le v e l  in  normal 
human serum.
A fter  separating  the very low d en sity  and p - lip o p r o te in s , the 
OLP were is o la te d  by seq u en tia l p rep arative  u ltr a c e n tr ifu g a t io n . The 
p u rity  o f  the separated OLP was determined by standard procedures, and 
the f in d in g s  w i l l  be presented  la te r  in  connection  w ith  s im ila r  charac­
te r iz a t io n  r e s u lt s  obtained for d e lip id iz e d  OLP.
The p u r if ie d  OLP was analyzed for  l ip id  and p ro te in  con ten t; the
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TABLE II





C h o lestero l
Phospho­
l ip id s T r ig ly cer id es
mg/100 ml mg/100 ml mg/100 ml
Human
(8) 23-35 Females 189+24 267+19 42+10
Human
(4) 22-28 Males 224+12 269+19 79+15
Horses
(18) 1-6 Mares 84+27 182+36 24+13
roUl
26
r e s u lts  are shown in  Table I I I .  The va lu es o f se v e r a l preparations  
were s im ila r  and d ia ly s i s  d id  n o t a lt e r  the com position . The CüLP o f  
both male and fem ale in d iv id u a ls  had the same com position . Compared 
w ith human serum CüLP, the (%LP o f horse serum contained  a h igher p ro te in  
content and a lower ch o le s te r o l/p h o sp h o lip id  (C/P) r a t io .
TABLE I I I
PER CENT COMPOSITION OF PURIFIED HUMAN 





















4 4 .4 2 2 .6 32 .8 0 .69
Horse 55.8 13.9 30.3 0 .46
Phospholip ids o f  Human Serum, Human OLP 
and Horse Serum
The phospholip id  com position  of p u r if ie d  OLP was determined  
by a combined s i l i c i c  ac id  column and s i l i c i c  ac id  impregnated paper 
chromatography. Each volume of OLP was ex tracted  i n i t i a l l y  w ith  
twenty volumes o f r e d i s t i l l e d  chloroform  and methanol (1 :1  v /v )  and 
washed three tim es w ith  d i s t i l l e d  w ater.
The phosphatide com position  o f human OLP was compared w ith  the 
average phosphatide d is tr ib u t io n  o f human and horse sera  (Table IV ). 
The per cen t d is tr ib u t io n  o f  sphingom yelin in  human serum OLP was
TABLE IV
PHOSPHOLIPID COMPOSITION OF PURIFIED OLP, NORMAL 
HUMAN AND HORSE SERUM
Per Cent o f  T otal L ip id  P
Sample Source




le c i t h in Cephalin
Phospho-
in o s i t o l Unknown
Serum Human 72.1 19.2 1 .0 2 .5 4 .8 1 .0
O&P Human
Male
79.2 13.8 1 .0 2 .5 3 .4 1 .3
OLP Human
Female
77.1 15.0 0 .2 2 .8 3 .6 0 .9
Serum Horse 80 .9 8 .8 4 .6 3 .8 0 .5 1 .4
N3
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lower than in  human serum but higher than in  horse serum.
The CtLF o f male and fem ale in d iv id u a ls  had s im ila r  phosphatide 
com position w ith  le c i t h in  and sphingom yelin as the p r in c ip a l phospho­
l ip id s .  Further su b fra c tio n a tio n  o f  the OLP between the d e n s it ie s  
1 .0 6 3 -1 .1 2 5  and 1 .1 2 5 -1 .2 1 0  g per ml showed no s ig n if ic a n t  change in  
the phosphatide d is tr ib u t io n . L y so le c ith in  was p a r tly  so lu b le  in  water 
which probably accounted for the low va lue in  OLP. Unwashed OLP con­
ta ined  about 5 per cen t ly s o le c it h in .  The plasm alogens were not sep­
arated from the cep h a lin  and le c i t h in .
Normal horse serum contained minute amounts o f  in o s i t o l  phos­
phatide compared w ith  human serum and OLP.
D elip id a tio n  o f OLP 
The p u r if ie d  OLP, d ia lyzed  a g a in st 0 .15  M NaCl, was d e lip id iz e d  
by e x tr a c tio n  w ith  e th a n o l-d ie th y l eth er (3 :1  v /v )  fo llow ed  by d ie th y l  
ether a t  -30°C in  a S oxh let apparatus. The e x tr a c ts  were analyzed for  
l ip id  and p ro te in  conten t and found to  con ta in  more than 90 per cen t  
of the o r ig in a l l ip id  components but no p ro te in  (Table V ). The l ip id -  
free  p ro te in  was recovered in  an 81 per cen t y ie ld .  However, th is  
e f f i c i e n t  method o f e x tr a c tio n  req u ires a m odified  S oxh let apparatus 
for the continuous eth er e x tr a c tio n .
P u r if ie d  QLP were subm itted, th e r e fo r e , to  a repeated batch- 
w ise e x tr a c tio n  w ith  a m ixture o f r e d i s t i l l e d  e th a n o l-d ie th y l ether  
(3 :1  v /v )  for  three days. The an a lyses o f l ip id  e x tr a c ts ,  shown in  
Table VI, gave rec o v e r ie s  o f l ip id s  and p ro te in  res id u e  comparable to  
those obtained by a more e lab orate  method o f continuous e x tr a c tio n .
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TABLE V
LIPID AND PROTEIN IN EXTRACTS AND RESIDUE FOLLOWING 
DELIPIDATION OF PURIFIED HUMAN SERUM QLP
Sample C h o lestero l
Phospho- T r ig ly -  
l ip id  cer id es
L ip id
P rote in
mg mg mg mg
QLP 19.3 3 3 .4  4 .3 55 .6
A lco h o l-e th er  ex tra c t 17 .8 2 7 .7  3 .7 -
Ether e x tr a c t 3 .3 2 .3  0 .1 -
P rote in  resid u e - - 4 5 .0
Percent recovery 94 90 88 81
TABLE VI
LIPID AND PROTEIN 
DELIPIDATION
IN EXTRACTS AND RESIDUE FOLLOWING 
OF PURIFIED HORSE SERUM QLP
Sample
Phospho- 




QLP 21.2 46 .0 85 .0
A lco h o l-e th er  e x tr a c t I 18.0 40 .7 -
A lco h o l-e th er  e x tr a c t  I I 0 .4 1 .0 -
A lco h o l-e th er  e x tr a c t  I I I  0 .1 0 .1 -
P ro te in  resid u e - 0 .5 78.1
P ercent recovery 87 .3 90.9 91.9
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The p ro te in  obtained a f te r  drying over D r ie r ite  in  a d e s s ic a ­
tor appeared g ra y ish -y e llo w  and amorphous and remained s ta b le  for  as 
long as a year when kept in  a stoppered g la s s  tube a t  10°G,
The p ro te in  was so lu b le  in  water and e le c t r o ly t i c  s o lu t io n s ,  
but i t s  s o lu b i l i t y  decreased a t  lower temperature and ac id  range o f  
pH. S o lu b il i ty  va lu es  in  a 0 .15 M NaCl, phosphate b u ffer  (pH 6 .8 ,  
u 0 .1 ) ,  sodium b arb itu ra te  (pH 8 .6 ,  u 0 .1 ) ,  and carbonate-phosphate  
(pH 9, u 0 .1 )  have been reported (65) p r e v io u s ly . The p ro te in  was 
r e a d ily  so lu b le  a t  pH v a lu es between 9 and 11 as w e ll as in  aqueous 
so lu t io n s  con ta in in g  1 to  8 M urea, 0 .0 4  to  0.1% sodium dodecyl s u lfa te  
(S .D .S .)  or 0.1% su c c in ic  anhydride.
In s o lu t io n , the p ro te in  was n o t as s ta b le  as in  th e dried  
form and showed evidence of dénaturation  w ith in  a few days. The dé­
n atu ration  process could  be delayed by u sin g  d eion ized  w ater and by 
keeping the p ro te in  in  d ilu te  base a t  0° to  3°C in  stoppered , c lean  
t e s t  tubes.
The d e lip id iz e d  QHP contained  le s s  than 2 per cen t phospho­
l ip id ;  there were no n eu tra l l i p i d s .
One sample o f human serum CKP was com pletely  free  o f  phosphorus 
a f te r  l ip id  e x tr a c tio n  w ith  m ethanol-chloroform  (1 :1  v /v ) .
A fter  d e s s ic a t io n  _in vacuo to  con stan t w eigh t, human and horse  
CXP contained  about 89 per cen t p ro te in  n itro g en . Most o f the remain­
ing e leven  per cen t o f the dry w eight was assumed to  c o n s is t  o f  
s tr u c tu r a l w ater.
Homogeneity o f  OLP and CÜP
The p u r ity  o f human and equine serum OLP and OJP was in v e s t ig a te d
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by se v e r a l methods:
A n a ly tic a l U ltr a c e n tr ifu g a tio n  
Ihe p u r if ie d  human and equine serum QLP, d ia ly zed  a g a in s t  0 .15  M 
sodium c h lo r id e  s o lu t io n , was su bjected  to  u ltr a c e n tr ifu g a t io n  a t  52,640  
r .p .m . and 20°C, The s c h lie r e n  p attern  showed a s in g le  sedim enting  
boundary in  both in sta n ces  and was not a lte r e d  by change in  con cen tration  
or pH.
The homogeneity o f the d e lip id iz e d  QLP was s im ila r ly  e s ta b lish e d  
by a n a ly t ic a l  u ltr a c e n tr ifu g a t io n . Both human and horse serum OP, 
d isso lv e d  in  0 .15  M sodium ch lo r id e  or phosphate b u ffer  (pH 8 .0 ,  u 0 .1 ) ,  
showed only one sedim enting boundary. R ep resen ta tive  samples o f  the  
s c h lie r e n  p a ttern s obtained for  both OLP and OP are provided in  Figures  
2 , 3 , 4 , and 5 .
Starch  Gel E lectro p h o resis  
A s in g le  p ro te in  band which m igrated towards the anode was found 
in  the e le c tr o p h o r e s is  o f p u r if ie d  human and horse serum OLP and CP on 
sta rch  g e l .  The p ro te in  band sta in ed  fo r  l ip id  in  the case  o f  OLP but 
n ot CP.
In e l e c t r o ly t i c  s o lu t io n s  human serum OLP m igrated approxim ately  
midway between a re feren ce  albumin band and the o r ig in , w h ile  horse  
serum OLP m igrated nearer to  the albumin band. Human and horse cP  
m igrated eq u a lly  as an im m ediately postalbum in band. The d if fe r e n c e  in  
m igration  between QLP and CP was o f va lu e in  studying recom bination of 
CüP w ith  l i p i d s .
Figure 2 . Human Serum OLP a t  30 (r ig h t)  
and 72 ( l e f t )  m inutes.
F igure 4 . Human Serum OP a t  25 (r ig h t)  
and 57 ( l e f t )  m inutes.
Figure 3 . Horse Serum 0!LP a t  19 (r ig h t)  
and 43 ( l e f t )  m inutes.
CO
to
Figure 5 . Horse Serum aP a t  28 (r ig h t)  
and 52 ( l e f t )  m inutes.
C oncentration o f P ro te in s  in  Sedim entation P atterns Approximately 7 mg 
per ml; A ll  Runs a t  52,640 r .p .m ., Temperature a t  20°C.
33
Agar Gel and Im m uno-electrophoresis 
Only one p ro te in  band was observed in  the e le c tr o p h o r e s is  o f  
human and equine QLP and OP on agar g e l .  The OLP band a ls o  sta in ed  for  
l ip id ,  but not OP.
The m igration  o f OLP was s im ila r  to  albumin on agar g e l w h ile  
OP m igrated on e-th ird  o f th at d ista n ce  from the o r ig in .
Im m unoprécipitation o f human serum OLP and OP w ith  anti-human 
horse serum showed only one narrow p r e c ip ita t io n  l in e  in  the same 
reg ion  where the p ro te in  band appeared. N either the OLP nor OP o f horse  
serum gave any c r o ss -r e a c tio n  w ith  the above antiserum .
Because anti-human horse serum contained  a n tib o d ies  a g a in st  
human serum OP, the la t t e r  was a n tig e n ic  and, th ere fo re , n ot id e n t ic a l  
w ith  horse serum OP.
Terminal Amino Acid R esidues 
The am ino-term inal amino ac id  i s  a sp a r tic  a c id  for both human 
and horse serum QLP and OP. The q u a n tita tiv e  r e c o v e r ie s  are shown in  
Table V II. Horse serum OP contained  approxim ately two umoles o f DNP- 
a sp a r tic  a c id  per umole o f p ro te in , assuming a m olecular w eigh t o f 70,000  
for OP, The human serum OP contained  s im ila r  amounts o f  DNP-aspartic 
acid  for the same m olecular w eigh t.
Prelim inary experim ents u sing the carboxypeptidase method as  
described  by Fraenkel-Conrat e t  (109) su g g est th a t threonine i s  
the carboxyl term inal amino ac id  o f both human and horse OP. The 
q u a n tita tiv e  y ie ld  o f the amino ac id  has n ot been c a lc u la te d .
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TABLE VII
AMINO-TERMINAL AMINO ACIDS OF HUMAN AND HORSE aP
Mole DNP-A sp artic
Acid per Mole o f  CüP *
Human CüP 1 .5
Horse CüP 1 .8
* Assumed M olecular w eight o f 70,000
B io lo g ic a l A c t iv ity  
The p ep tid e m oiety o f  human 0!LP and OCP was lab eled  w ith  I^^^, 
passed through a s t e r i l i z e d  u ltr a f in e  f i l t e r  (P y rex ), then r e in je c te d  
in to  normal human in d iv id u a ls . The r a d io a c t iv ity  disappearance ra te  
for ten  days a f te r  in je c t io n  was p lo tte d  on sem ilog paper and h a lf -  
tim es determined g ra p h ic a lly . The h a lf-t im e s  for  both QLP-I^^^ and 
aP-I^^^ were approxim ately 3 .5  days as shown in  Figure 9 .
Recombination of CüP w ith  L ip ids  
The l l3 1 - la b e le d  CüP was added in  tra ce  amounts (0 .1  to  1 .0  mg 
per 100 ml) to  n a tiv e  serum and recom bination w ith  l ip id s  e s ta b lish e d  
by p rep arative  u ltr a c e n tr ifu g a t io n  and sta rch  g e l  e lec tr o p h o r e s is  
a fte r  an incubation  period  o f 30 m inutes a t  about 20°C ^  v i t r o .
When CüP-ll31 was su bjected  to  u ltr a c e n tr ifu g a t io n  a t  105,000 xg , 
a t  0°C for  22 or 44 hours in  a NaCl-KBr so lu t io n  o f d en sity  1.210 g per 
ml, approxim ately 4 per cen t o f the r a d io a c t iv ity  was p resen t in  the  
supernatant fr a c t io n  and the remaining 96 per c en t was in  the in fr a -  
n atan t. However, when o P - ll3 1  or CüLP-1^31 was added to  normal serum
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o f so lv e n t  d en sity  I . 210 g per ml and cen tr ifu g ed  under the same con d i­
t io n s ,  about 70 per cen t o f the r a d io a c t iv ity  a f te r  22 hours o f c e n tr i­
fu ga tion  and 85 per cen t a f te r  44 hours were found in  the supernatant. 
This in d ic a te s  th a t recombined w ith  serum l ip id  to  form lab eled
QLP o f d en sity  le s s  than 1.210 g per ml and th erefo re  underwent f l o t a ­
t io n  upon c e n tr ifu g a t io n .
Starch g e l  e le c tr o p h o r e s is  was employed a ls o  to  demonstrate 
recom bination o f  QP w ith  serum l i p i d s .  Follow ing the e le c tr o p h o r e s is  
o f Q!P-I^^^, the s ta rch  g e l  was s ta in ed  w ith  Amido Black B, cu t in to  
1 cm s e c t io n s , and r a d io a c t iv ity  o f  each s e c t io n  determined in  a w e l l -  
type c r y s ta l  s c i n t i l l a t i o n  cou n ter. R a d io a c tiv ity  was d etected  only  
in  the reg ion  o f th e  CüP band i . e .  im m ediately post-album in reg io n , as 
in d ica ted  p rev io u s ly . However, when a tracer amount o f CüP-I^^  ^ was 
f i r s t  added to  normal serum and then su bjected  to  e le c tr o p h o r e s is , the  
r a d io a c t iv ity  was d e tec ted  in  the QLP reg io n . This again in d ic a te s  
th a t CÜP-1 I 3 I recombined w ith  serum l ip id s  to  form the slow er moving 
QLP m olecu les.
These experim ents were performed on both  human and horse CÜP and 
the r e s u lt s  were the same w ith in  experim ental erro r .
Furthermore, human serum aP-%131 added to  horse serum in  v i t r o  
recombined w ith  serum l ip id s  to  form la b e led  QLP. S im ila r ly , horse  
serum QP-1^31 recombined w ith  human serum l ip id s  _in v it r o  to  form 
la b e led  QLP.
From th ese  experim ental f in d in g s , i t  may be concluded th a t both  
QLP and OP o f human and horse serum were e le c tr o p h o r e t ic a lly  homogeneous 
and th a t the d e lip id iz e d  QLP was b io lo g ic a l ly  a c t iv e .
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Amino Acid A nalysis  
The amino ac id  com position  o f human CUP resem bled th at o f the 
horse CUP (Table V II I ) . The va lu es referred  to  p ro te in  m oiety dried  
to  co n stan t w eight in  a vacuum d e ss ic a to r  over P2 O5 . Both p ro te in  
res id u es  showed only tra ces  o f on e-h a lf c y s t in e  and had s im ila r  va lu es  
for amide n itrogen  and ammonia. The amino acid  res id u es  per sm a lle s t  
th e o r e t ic a l  u n it  were d if f e r e n t ,  although glutam ic a c id , le u c in e , 
ly s in e ,  a sp a r tic  a c id , a rg in in e  and a lan in e were the p r in c ip a l amino 
a c id s . The sm a lle st  human CUP u n it  (c a lc u la t io n s  based on is o le u c in e )  
gave a m olecular w eight o f about 2 0 , 0 0 0 ; th is  i s  in  agreement w ith  the  
fin d in g s  o f  Shore and Shore ( 6 6 ) .  The sm a lle st  horse CUP u n it  (c a lc u ­
la t io n s  based on m ethionine) gave a w eight o f  28 ,500 .
These r e s u lt s  show th a t the stru ctu res  o f  human and horse CUP 
may d i f f e r  in  d is tr ib u t io n  o f  amino ac id s as w e ll as in  s iz e  o f the  
sm a lle s t  th e o r e t ic a l u n it .
Enzymatic H ydrolysis of CUP 
A liq u ots o f s a l t - f r e e  tr y p t ic  and chym otryptic h yd rolysates o f  
human and horse serum CUP con ta in in g  approxim ately 1 .5  mg of peptide  
m a ter ia l were developed chrom atographically in  one dimension and by 
high  v o lta g e  e le c tr o p h o r e s is  in  the second dim ension, and peptide sp ots  
were id e n t if ie d  w ith  the n inhydrin  re a c tio n .
The peptide p a ttern s o f tr y p t ic  d ig e s ts  o f human and horse  
serum CUP were d if fe r e n t  (F igure 6 ) .  Spots 1, 2 , 3 , 17, and 18 of the  
human serum CUP p attern  were absent from the horse CUP p a ttern . On the  
other hand, spots 9 , 10, 17, and 18 in  the la t t e r  were m issing from the
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TABLE VIII










R esid u es/u n it*
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Leucine 11.73 17 15.35 30
Lysine 9.29 13 9 .71 19
A spartic acid 7.45 11 9 .02 17
A rginine 6.39 9 7.36 14
A lanine 4 .91 7 5 .78 11
Serine 4 .91 7 4 .62 9
V aline 4 .34 6 4 .7 1 9
Tyrosine 4 .31 6 3.29 6
Threonine 4 .06 6 5 .06 10
P ro lin e 3 .15 5 3 .05 6
P henylalanine 3.03 4 3 .66 7
G lycine 2 .2 3 2 .65 5
H istid in e 1.79 3 2 .4 5
Tryptophane 1.76 3 2 .47 5
M ethionine 1.18 2 0 .52 1
Iso leu c in e 0.69 1 0 .98 2
1/2 C ystine trace trace trace trace
Ammonia 1.13 2 1.33 3
Amide N itrogen  
Tc— rz— :—7:------









Figure 6 . P eptide P attern  o f Human and Equine Serum (%P 
D ig ests  Obtained w ith  Trypsin,
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Figure 7 . Peptide P attern  o f  Human and Equine Serum (%P 
D igested  S u ccess iv e ly  w ith  Trypsin and Chymotrypsin.
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form er. Both human and horse serum CüP, however, appeared to  have s im i­
la r  p ep tid es  in  the lower h a lf  o f the p a ttern s .
Ihe su cc e ss iv e  h y d ro ly s is  o f human and horse OP w ith  try p s in  and 
chymotrypsin a ls o  r e su lte d  in  d is s im ila r  p ep tid e pattern s (F igure 7 ) .  
Spots 9 , 10, 11, 14, 15, 16, and 29 in  the human serum CüP p attern  were 
not seen on the horse serum CüP p attern .
These r e s u lt s  su ggest th a t the amino a c id  sequence o f  human and 
horse serum OP are n ot the same.
Behavior o f Human and Horse Serum 
OP in  Various Aqueous S o lu tio n s
S evera l methods were used to  in v e s t ig a te  the r e v e r s ib le  d is s o ­
c ia t io n  o f OP in  aqueous s o lu t io n . The fin d in g s  are summarized in  
Table DC and X.
Human serum OP d isso lv e d  in  e l e c t r o ly t i c  so lu t io n s , pH 7 to  8 , 
appeared as two ad jacent p ro te in  bands and two s c h lie r e n  boundaries 
w ith in  48 hours (F igure 8 ) .  The major boundary had a sedim entation  
c o e f f i c ie n t  o f 4 .1  S and the minor boundary a va lu e  o f 7 .7  S. Only 
the major boundary and a s in g le  e le c tr o p h o r e tic  p ro te in  band on starch  
g e l e le c tr o p h o r e s is  appeared, however, fo llo w in g  the ad d itio n  o f urea  
(1 to  8 M) or in crea sin g  the pH to  11 .0  by a d d itio n  o f a lk a l i  (F igure 8 ) .  
The minor boundary did n ot reappear upon d ia ly s i s  o f the urea a g a in s t  
0 .15  M NaCl so lu tio n  or a f te r  rea d ju stin g  the pH to  7 .0  or 8 .0 .
Sodium dodecyl s u lfa te  (0.1% or le s s )  caused the d is s o c ia t io n  o f  
human and horse OP to  a p ro te in  u n it  w ith  sed im entation  c o e f f i c ie n t  o f  
about 2 .5  (F igure 8 ) .  Only one p ro te in  band appeared on starch  or agar 
g e l  w ith  an e le c tr o p h o r e tic  m o b ility  tw ice th a t o f the o r ig in a l OP in
TABLE IX
BEHAVIOR OF HUMAN OP IN VARIOUS AQUEOUS SOLUTIONS
P ro te in  Bands 
on Starch
Media and A dditions Gel
Boundaries 
in  S ch lieren  
P attern S
M o b ility  on 
Agar Gel
Sodium ch lo r id e  (0 .1 5  M); pH 7 1 or 2 1 or 2 " Regular (R)
Phosphate b u ffer  (u 0 .0 5 , 0 .1 ) ;  pH 8 .0 1 or 2 1 or 2 4 .1  and 7 .7 R
B arbiturate b u ffer  (u 0 .1 ) ;  pH 8 .0 1 or 2 1 or 2 - R
NaCl (0 .1 5  M); a lk a l i  to  pH 11 .0 1 1 - R
Phosphate b u ffer  (u 0 .1 ) ;  a lk a l i  to  pH 11.0 1 1 4 .0 R
Urea (1 -8  M); pH 6 .0 1 1 - R
Urea (2 M); d ia ly s i s  a g a in s t  NaCl (0 .1 5  M) 1 1 - R
NaCl (0 .1 5  M); urea (2 -6  M) 1 _  V R
Phosphate b u ffer  (u 0 .1 ) ;  urea (1 -8  M) 1 1 4 .0 R
Sodium dodecyl s u lfa te  (S .D .S . 0.04-0.1% ) 1 1 - Increased
Phosphate b u ffer  (u 0 .1 ) ;  S .D .S . (0.08%) 1 1 2 .5 Increased
S .D .S . (0.08% ); d ia ly s i s  a g a in st NaCl (0 .1 5 M) 1 1 3 .9 R
S u cc in ic  anhydride (0.1% ); a lk a l i  to  pH 9 .0 1 1 - Increased
H*
TABLE X
BEHAVIOR OF HORSE CtP IN VARIOUS AQUEOUS SOLUTIONS
P rote in  Band Boundary M ob ility  on
Media and A dditions on Starch in  S ch lieren S Starch  and
Gel P attern Agar Gel
Phosphate b u ffer  (u 0 .1 ) ;  pH 8 .0 1 1 3 .9  Regular
Phosphate b u ffer  (u 0 .1 ) ;  a lk a l i  to  pH 11 .0 1 - »•
Urea (1 -2  M) 1 - "
Sodium Dodecyl S u lfa te  (0.08%) 1 1 2 .9  Increased
S .D .S . (0.1% ); d ia ly s i s  a g a in s t  NaCl (0 .1 5  M) - 2 -




Figure 8 . Sedim entation P atterns o f Human CÜP in  Phosphate B uffer (u 0 .1 )  a t  (A) pH 8 .0 ,  
(B) pH 1 1 .0 , (C) P lus Sodium Dodecyl S u lfa te  (0.1% ), and (D) A fter  Removal o f Sodium 
Dodecyl S u lfa te  by D ia ly s is .  In te rv a l Between Photographs was 16 M inutes, P ro te in  
C oncentration 7 mg per ml. C en tr ifu ga l Speed 52,640 r .p .m . a t  20°C.
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phosphate b u ffer  under s im ila r  c o n d itio n s .
The a d d itio n  o f su c c in ic  anhydride (0.1%) to  an aqueous so lu ­
t io n  o f human or horse 03P increased  the e le c tr o p h o r e tic  m o b ility  o f the 
p r o te in  m oiety on agar g e l .  S u cc in y la tio n  did  not decrease the binding  
ca p a c ity  o f CüP, nor the immunologic response o f  human serum QŒ*.
A fter  the removal o f sodium dodecyl s u lfa te  from the so lu tio n  
by d ia ly s i s  a g a in st  0 .15  M NaCl, the human OT rea sso c ia te d  to  form the 
p r o te in  u n it  w ith  the i n i t i a l  e le c tr o p h o r e tic  m o b ility  and sedim entation  
c o e f f i c ie n t  o f about 4 .0  S (F igure 8 ) .  Follow ing the removal o f sodium 
dodecyl s u lf a t e ,  horse CÛP appeared as two boundaries showing th at  
r e a s s o c ia t io n  might have occurred.
The ^  v it r o  recom bination technique showed th a t human and horse 
d isso lv ed  in  any of the described  aqueous so lu t io n s  a t  h igh pH 
or con ta in in g  urea, sodium dodecyl s u lfa t e  or su c c in ic  anhydride main­
ta in ed  the b io lo g ic a l  fu n ctio n  o f binding serum l ip id s .  I t  was demon­
s tr a te d  a ls o  by agar Im m unoelectrophoresis th a t human serum 
d is so lv e d  in  various b u ffe r s  a t  pH 7 to  11, in  urea, sodium dodecyl 
s u lf a t e  (0.08%) or su c c in ic  anhydride (0.1%) so lu t io n s , gave a s in g le ,  
d is t in c t  p r e c ip ita t io n  l in e  w ith  horse anti-serum .
I t  was concluded from th ese  r e s u lt s  th a t human and horse (%P 
underwent a r e v e r s ib le  d is s o c ia t io n  w ith  an io n ic  d eterg en t, and th a t  
a t  l e a s t  human serum 0(B formed aggregates in  e l e c t r o ly t i c  so lu t io n  
which were d isrupted  w ith  increased  pH or ad d itio n  o f urea w ithout lo s s  
o f b io lo g ic a l  a c t iv i t y .
Behavior o f  QLP in  Sodium Dodecvl S u lfa te  
The a d d itio n  o f  sodium dodecyl s u lfa te  to  human and horse (%LP
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did  n ot a l t e r  the e le c tr o p h o r e tic  m o b ility  nor the sedim entation  
c o e f f i c ie n t  (4 .5  to  5 .0  S ) .
As in  the case o f  Of, ad d itio n  o f sodium dodecyl s u lfa t e  (0.1%) 
to  human serum OLP did not b lock the immunoprecipitin rea c tio n  w ith  
horse anti-serum  on agar g e l .
F in a lly , OLP trea ted  w ith  sodium dodecyl s u lfa te  was n o t d e lip id -  
ized  by th e d eterg en t. Starch g e l  e le c tro p h o res is  showed the OLP band 
to  s ta in  p o s it iv e ly  for p ro te in  and l ip id .
Using the ^  v it r o  recom bination procedure, QP-I^^l^ incubated  
w ith  normal serum conta in ing  sodium dodecyl s u lfa te  (0.1% ), recombined 
w ith  the serum lip id s  to  form lab eled  OLP to  the same ex ten t as in  the 
absence o f  the d etergent i . e .  about 85% of the r a d io a c t iv ity  o f  OP-I^^l 
was found in  the 1.210 g per ml supernatant fo llo w in g  c e n tr ifu g a tio n  a t
105,000 X g , QOC for 44 hours.
These r e s u lt s  in d ica ted  th a t the b io lo g ic a l  and p h y sica l charac­
t e r i s t i c s  o f OLP were n o t a lte r e d  s ig n if ic a n t ly  by sodium dodecyl 
s u lf a t e .
Id e n tity  o f P ro te in  M oiety o f Human 
Serum VHDLP
The sera  o f normal male and fem ale su b je c ts , incubated w ith  
O f - l lS l  or OLP-I^^^ for 30 m inutes a t  20°C, were subjected  to  u lt r a ­
c e n tr ifu g a tio n  (105,000 X g for  44 hours a t  0°C) a fte r  ad ju stin g  the
so lv e n t  d en sity  to  1.210 g per ml and subsequently separated in to  two 
fr a c t io n s  w ith  the Spinco tube s l i c e r ,  as described  p rev io u sly . The 
in fra n a ta n t fr a c t io n  (VHDLP) contained  8 to  12 per cen t o f the t o t a l  
serum l ip id  phosphorus and 10 to  15 per cen t o f  the to ta l  r a d io a c t iv ity
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of or in  the o r ig in a l in cu b ation  m ixture, but no c h o le s ­
t e r o l .
The l ip id  phosphorus in  VHDLP, ex tra c ted  w ith  chloroform -m eth- 
anol and analyzed by s i l i c i c  acid  column and paper chromatography, was 
id e n t i f ie d  as p h o sp h o lip id s. L y so le c ith in , the p r in c ip a l component, 
accounted for  about h a lf  the t o t a l  l ip id  phosphorus o f VHDLP in  two 
separate determ inations (Table X I).
TABLE XI
PER CENT PHOSPHATIDE COMPOSITION OF VHDLP
Chloroform- % Eluted
% T ota l L ip id  P
S olu b le from Lyso­ L ec i­ Sphingo­ Cepha- Ino­
Unknownug P Column le c i t h in th in m yelin l in s i t o l
155 93 47 22 5 3 18 3
401 94 56 28 10 2 2 2
The p h osp h o lip id -con ta in in g  VHDLP were p resen t, th ere fo re , 
along w ith  OP-I^^^ in  the 1.210 g per ml in fran atan t fr a c t io n . An 
attem pt was made to  show th a t the phospholip ids might be bound to  CüP.
F ir s t ,  i t  was a lready demonstrated th a t a trace  amount o f  
O P -ll31  added to  serum was com pletely  bound to  l ip id s .
Second, the 1.210 g per ml in fra n a ta n t was concentrated  by 
repeated  u ltr a c e n tr ifu g a t io n  and a sample con ta in in g  the VHDLP was 
s ta in ed  w ith  Sudan Black B, according to  the procedure d escrib ed  by 
Zakelj and Cross (114) and ap p lied  on s ta rch  g e l .  The m igration  o f the 
p resta in ed  VHDLP was in  the immediate post-album in reg io n  and c o r r e s -
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ponded w ith  the sta rch  g e l  s e c t io n  where the r a d io a c t iv ity  o f  the 
q;P_i 131 d e tec ted .
Third, an a -p ro te in -p h o sp h o lip id  complex was obtained by 
p a r t ia l  d e lip id a t io n  o f the p u r if ie d  QLP w ith  eth er  a t  0°C for  24 hours 
(7 0 ) . The e le c tr o p h o r e tic  m o b ility  was s im ila r  to  those o f p resta in ed  
VHDLP as w e ll as oP -I^^ l the 1.210 in fra n a ta n t.
F in a l ly ,  the p ro te in s  in  the 1.210 g per ml in fran atan t fr a c t io n  
were trea ted  w ith  ra d io io d in e  and incubated w ith  u n lab eled , p u r if ie d  
QLP for 30 m inutes a t  20°C. Subsequently, the added QLP separated  and 
p u r if ie d  u ltr a c e n tr ifu g a lly  a t  105,000 x g was found to  be la b e le d .
The r e s u lt s  o f  the above experim ents in d ica te d  th a t OP could  
be the p ro te in  m oiety o f  the VHDLP.
In Vivo Recombination and Turnover S tu d ies
The time course o f plasma r a d io a c t iv ity  a f te r  the intravenous  
in j e c t io n  o f OLP-I^^l or QP-I^^l to  the th ree  normal su b jec ts  and the  
p a tie n t  (J .C .)  w ith  id io p a th ic  h yp erch olestero lem ia  were s im ila r ;  the 
h a lf  tim es averaged 3 .5  days. In the p a t ie n ts  (H.H. and S .H .) w ith  
hyperchylomicronemia (d ie ta r y  fa t-in d u ced  h yp erg lycerid em ia), the h a l f -  
tim es were 1 .7  and 1 .9  days, w h ile  in  p a t ie n ts  (O.W. and O.C.) w ith  
d ie ta ry  carbohydrate-induced hyperlipem ia, the h a lf-t im e s  were 2 .5  and 
2 .7  days, r e s p e c t iv e ly .
In p lo t t in g  plasma r a d io a c t iv ity  a g a in s t  tim e, the 30 minute 
p o s t - in je c t io n  va lu es  f e l l  in  the period o f m ixing and rapid  d e c lin e  
in  r a d io a c t iv ity  and were n o t p lo tte d  in  Figure 9 . The period  of rapid  
d e c lin e  was com plete w ith in  24 to  48 hours a f te r  in je c t io n , and only
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Figure 9 . Time Course o f  Plasma R a d io a c tiv ity  Follow ing
or CKP-1 I 3 I  In je c t io n  in  Normal and H yperlipidém ie  
In d iv id u a ls . See t e x t .
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the lin e a r  p lo ts  (F igure 9) which follow ed  the la t t e r  period were used  
to  c a lc u la te  h a lf - t im e s .
Plasma sam ples, obtained from normal and hyperlip idém ie su b jec ts  
a f te r  an overnight f a s t ,  two and on e-h a lf hours p o s t - fa t ty  meal, and 
h a lf  an hour a f te r  a subsequent heparin in je c t io n ,  were separated u lt r a ­
c e n tr ifu g a lly  in to  supernatant and in fran atan t fr a c t io n s  a t  three  
d if fe r e n t  d e n s it ie s  and the r a d io a c tiv ity  o f each fr a c tio n  determ ined. 
The plasma was a ls o  analyzed for to ta l  c h o le s te r o l ,  p h osp h olip id s, 
tr ig ly c e r id e s  and fr e e  fa t ty  a c id s . Xiie r e s u lt s  are presented  in  
Table X II.
The va lu es  fo r  t o t a l  c h o le s te r o l were n o t in flu en ced  by a f a t  
d ie t  or heparin . P hospholip ids were increased  by the d ie t  in  su b jec ts
S.H. and H.H. w h ile  the tr ig ly c e r id e s  increased  in  a l l  su b je c ts . 
Follow ing heparin in je c t io n ,  the p ostprand ia l tr ig ly c e r id e  le v e l  dropped 
and the free  fa t ty  ac id  le v e l  was e lev a ted , presumably through r e le a s e  
of lip o p r o te in  l ip a s e .  However, su b jec ts  S.H. and H.H. were r e la t iv e ly  
le s s  responsive to  heparin  adm in istration  (Table X II ) .
The d is tr ib u t io n  o f o!LP-I^^^ r a d io a c t iv ity  in  the 1.006 g per ml 
fr a c t io n s  i s  shown in  Table X III. In the normal su b jec t (P .G .), the 
hyperlip idém ie su b jec ts  (O.W. and O.C.) and the hyperc h o ie s tero lem ic  
su b jec t ( J .C .) ,  n e ith er  the in g estio n  o f a f a t ty  meal nor subsequent 
heparin ad m in istra tion  had any s ig n if ic a n t  e f f e c t  on the d is tr ib u t io n  
of r a d io a c t iv ity  in  the 1 .006  g per ml supernatant and in fran atan t  
fr a c t io n s . In three s tu d ie s  w ith  su b jec t H.H, and two s tu d ie s  w ith  
su b jec t S .H ., an in cr ea se  in  the r a d io a c t iv ity  o f the 1.006 g per ml 
supernatant was observed two and o n e-h a lf hours a f te r  a fa t ty  m eal.
TABLE XII
EFFECT OF FAX MEAL AND SUBSEQUENT HEPARIN INJECTION ON SERUM 
LIPIDS OF NORMAL AND HYPERLIPIDEMIC SUBJECTS
S u bject Age Sex
T ota l C h o lestero l, 
F* PP** PH
Phospholip ids  
F PP PH
T rig ly cer id es  
F PP PH
Free F atty  Acids 
F PP PH
mg % mg % uEq/1
P.G. 56 M 244 - - 300 316 312 57 345 58 - 318 1236
H.H. 27 M 288 264 252 345 360 342 3112 3580 3000 - - -
H.H. I t I t 256 264 278 296 350 372 2420 2525 2285 588 596 761
H.H. I t II 252 248 226 310 346 345 2185 2525 2625 456 378 723
S.H. 15 F 96 101 102 140 148 200 478 790 689 - 350 525
S.H. I t I t 96 110 115 162 210 205 818 1058 988 395 271 723
O.W. 51 M 228 - - 328 320 318 636 889 605 - 312 667
O.C. 65 M 244 238 256 350 385 402 709 1093 872 - 408 2384
J .C . 34 M 424 440 436 326 392 377 92 228 126 485 761 1312
L nO
F = F astin g ; PP = P ostp ran d ia l; PH = Postheparin
TABLE XIII
EFFECT OF FAT MEAL AND SUBSEQUENT HEPARIN INJECTION ON 
DISTRIBUTION OF caP -I^ ^ l RADIOACTIVITY IN CENTRIFUGE FRACTIONS
Subject
Percent R a d io a c tiv ity  in  1 .006 g per ml F ractions  
F astin g  P ostp ran d ia l Postheparin  
Supernatant In franatan t Supernatant In franatan t Supernatant In franatan t
S .S . 3 97 - - - -
P.B. 6 94 - - - -
P.G. 5 95 6 94 6 94
H.H. 6 94 31 69 16 84
H.H. 15 85 24 76 22 78
H.H. 9 91 30 70 18 82
S.H. 10 90 13 87 14 86
S.H. 14 86 19 81 20 80
O.W. 8 92 10 90 10 90
O.C. 6 94 7 93 7 93
J.C . 6 94 7 93 7 93
L n
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In su b jec t H.H. heparin in je c t io n  r e su lte d  in  red u ction  of r a d io a c t iv ity  
in  the 1.006 g per ml supernatant to  va lu es c lo se r  to  fa s t in g  le v e ls .
The r a d io a c t iv ity  in  the 1.063 g per ml supernatant and 
in fran atan t fr a c t io n s  o f a l l  sera  was s im ila r  to  th a t o f  the 1.006 g 
per ml fr a c t io n s .
The 1.210 g per ml supernatant fr a c tio n s  contained  in  a l l  sera  
about 70 per cen t o f the to ta l  r a d io a c t iv ity  per sample a f te r  22 hours 
of c e n tr ifu g a tio n  a t  105,000 x g . This i s  c o n s is te n t  w ith  the in  v i t r o  
fin d in g s a lready d escrib ed .
Subject H.H. a ls o  rece iv ed  ra d io iod in a ted  human serum albumin 
(Abbott) in tra v en o u sly , and i t  was observed th a t le s s  than 7 per cen t  
o f the r a d io a c t iv ity  o f  the serum could be accounted for  in  the 1.210 g 
per ml supernatant, and th a t n e ith er  a fa t ty  meal nor subsequent heparin  
in je c t io n  had any e f f e c t  on the d is tr ib u t io n  o f  r a d io a c t iv ity .
Urinary E xcretion  o f L ip id s and QLP-I^^^ in  
a P a tien t w ith  the N ephrotic Syndrome
The aLP-1^31 was adm inistered in traven ou sly  to  a 14-year-o ld  
female p a tie n t  w ith  the n ephrotic syndrome a sso c ia te d  w ith  ren al b iopsy  
fin d in g s o f  subacute g lom eru lon ep h ritis . The blood urea n itrogen  
ranged between 23 and 32 mg per 100 ml and the intravenous pyelogram  
showed both kidneys w ith  good excretory  fu n ctio n . The p a tie n t  had 
hypoalbuminemia, p ro te in u r ia , and hyperlip idem ia as shown in  Table XIV. 
The t o t a l  serum c h o le s te r o l,  p h osp h o lip id s, t r ig ly c e r id e s  and free  
fa t ty  a c id s  were in creased . The serum lip o p r o te in  d is tr ib u t io n  was 
determined on two samples and the average va lu es presented  in  Table XV. 
There was an in crease  in  the lip o p r o te in s  o f a l l  c la s s e s  o f low d en sity
TABLE XIV
SERUM AND URINE LIPIDS AND PROTEINS OF A PATIENT 
WITH lÎEPHROTIC SYNDROME
Date Sample
C h o lestero l 









P ro te in  Gm 
T otal A/G R atio
3 -6 —63 Serum* 755 78 670 528 - 3 .8 0 .7 /3 .1
3-10-63 Serum 640 - 655 480 803 - -
3-22-63 Serum 861 67 743 534 - 5 .0 0 .4 /4 .6
3-6-63 Urine** 11.1 - 8 .1 3 - 9 .8 7 .2 /2 .6
3-7-63 Urine 8 .2 41 6 .1 - - - -
3-22-63 Urine 6 .0 - 6 .7 - - 10.9 8 .3 /2 .6
L nW
Values reported  per 100 ml serum 
**Values correspond to  24-hour ex cr e tio n  in  urine
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lip o p r o te in s  and a decrease in  the per cen t d is tr ib u t io n  o f  QLP.
Follow ing 0LP-i 131 in je c t io n ,  blood was obtained a f te r  10 
m inutes, 12 and 24 hours, and u rin e was c o l le c te d  a t  3 -h o u r -in terv a ls  
for  24 hours and subsequently  two 24-hour urine c o l le c t io n s .
TABLE XV
LIPOPROTEIN DISTRIBUTION IN A PATIENT WITH 
NEPHROTIC SYNDROME
L ipoprotein L ipid  per 100 ml of Serum
<1 .006 1.006-1,.019 1 .019 -1 .063 > 1 . 063
mg 7o mg % mg X mg 7o
C h o lestero l 130 18 105 13 468 61 62 8
Phospholip ids 141 21 88 13 384 58 50 8
The to ta l  r a d io a c t iv ity  o f serum and urine was recorded in  a 
w e ll-ty p e  c r y s ta l s c i n t i l l a t i o n  counter. Urine was passed through  
lo r e s in  (Abbott) to  remove fr e e  io d in e , and an a liq u o t  was counted for  
protein-bound io d in e  i . e .  QP-I^^l,
Approximately 47 per cen t of the r a d io a c t iv ity  disappeared from 
serum 24 hours a fte r  in j e c t io n .  Of t h i s ,  38 per cen t was p resen t in  the  
u r in e . The second and th ird  24-hour urine c o l le c t io n s  contained  10 and 
5 per cen t o f the i n i t i a l  dose o f  r a d io a c t iv ity ,  r e s p e c t iv e ly .
In a l l  u rin e fr a c t io n s  c o l le c te d  during the f i r s t  72 hours a f te r  
in je c t io n ,  there was QP-I^^^ averaging about 9 per cen t o f  the to ta l  
u rin e r a d io a c t iv ity .  None of the urine o P -ll3 1  was found in  the 1.063  
g per ml supernatant fr a c t io n , approxim ately 25 per cen t was p resen t in
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the 1.210 g per ml supernatant, and the remaining 75 per cen t was in  the
1 .210 g per ml in fra n a ta n t. The urine CtP-I^^l had an e le c tr o p h o r e tic  
m o b ility  on sta rch  g e l  s im ila r  to  n a tiv e  serum
The u rin e  contained  sm all amounts o f c h o le s te r o l and phospho­
l ip id s ,  as shown on Table XIV. Follow ing in  v i t r o  incubation  of urine  
w ith  a tra cer  amount o f  and u ltr a c e n tr ifu g a t io n , the 1.210 g per
ml supernatant contained  30 per cen t o f the r a d io a c t iv ity .
From the r e s u lt s  o f the above experim ents, i t  was concluded th a t  
qLP-i 131 ^ag ex creted  as such in  the urine and th a t u rin e l ip id s  o f  
n ephrotic  p a t ie n ts  could bind w ith to  form lab eled  QLP.
CHAPTER IV 
DISCUSSION
Human and Horse Serum OLP 
The p r o te in  m oiety o f human serum OLP was s u c c e s s fu l ly  is o la te d  
by Scanu, Lewis and Bumpus (60) and the homogeneity was p a r t ia l ly  e s ta b ­
lish ed  by a n a ly t ic a l  u ltr a c e n tr ifu g a t io n , moving boundary and starch  
g e l e le c tr o p h o r e s is , s o lu b i l i t y ,  and N -term inal amino a c id  (6 0 ) . The 
r e s u lt s  o f our experim ents on the sep aration  and c h a ra c te r iza tio n  o f  
human serum OLP and OCP using id e n t ic a l  methods and d e lip id a t io n  proced­
ure are in  agreement w ith  those reported  by Scanu e t  a l .
The f i r s t  lip o p r o te in  fr a c t io n  o f  con stan t com position to  be 
is o la te d  by Macheboeuf (5) was a h igh d en s ity  lip o p r o te in  obtained  
from horse serum. However, there i s  very l i t t l e  inform ation regarding  
the chem ical com position  and p hysico-chem ical c h a ra c te r iza tio n  o f th is  
lip o p r o te in  or i t s  p ro te in  m oiety . S ince horse OLP can be obtained  
in  h igh  y ie ld  and might serve as a r e a d ily  a v a ila b le  model substance  
for binding s tu d ie s ,  i t  was o f in t e r e s t  to  study i t s  p ro p ertie s  and 
compare them w ith  those from sim ila r  s tu d ie s  o f  human serum QLP.
The horse QLP (d 1 .063 -1 .210  g per ml) and i t s  l ip id - f r e e  
p rote in  m oiety were ch aracterized  by a n a ly t ic a l  u ltr a c e n tr ifu g a t io n ,  
e le c tr o p h o r e s is , end-group a n a ly ses , and recom bination o f the r a d io io -
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dinated  CüP toward l ip id s .  The r e s u lt s  o f  th ese  s tu d ie s  provide p a r t ia l  
evidence for  the homogeneity o f  th ese  prep aration s.
I t  was o f in t e r e s t  to  fin d  th a t human and horse 0Œ* which have 
s im ila r  l ip id  transport fu n ctio n s in  plasma shares sev era l ch aracter­
i s t i c s  such as sed im entation  and e le c tr o p h o r e tic  m o b il i t ie s ,  term inal 
amino a c id s , recom bination ca p a c ity  towards l ip id ,  and behavior in  
aqueous media.
However, human and horse CüP were immunochemically d is t in c t .
They d if fe r e d  further in  r e sp e c t to  amino acid  com position , m olecular  
w eights for the sm a lle s t  th e o r e t ic a l  u n it  o f amino acid  r e s id u e s , and 
sequences o f  amino ac id s  in  the p ep tid e chains as demonstrated by the 
d is s im ila r  p ep tid e p attern s o f th e  enzymic d ig e s ts  w ith  chymotrypsin  
and try p s in .
These r e s u lt s  in d ica ted  th a t , in  s p it e  o f  some chem ical d i f ­
fere n c es , horse OP i s  s u f f i c ie n t ly  s im ila r , in  r e sp ec t to  b io lo g ic a l  
p ro p e r tie s , to  human OP to  j u s t i f y  i t s  use as a compound for  fu ture  
binding s tu d ie s  and for  the ev a lu a tio n  o f  the types o f  noneovalent 
bonds th a t e x i s t  between the l ip id  and p ro te in  m o ie t ie s . B asic in ­
form ation regarding s i z e ,  com position  and physico-chem ical p ro p ertie s  
of the lip o p r o te in  would be required  to  e lu c id a te  the complex s tru c ­
ture o f the l ip id -p r o te in  a s so c ia t io n .
In th is  regard, ob servation s o f sev era l researchers (7 1 ,7 2 ,
83) support an hyp othesis which su ggests  th a t the p ro te in  i s  p laced  
a t  or c lo se  to  the su rface o f l ip id  spheres, or th a t a lip o p r o te in  model 
c o n s is ts  of a l ip id  core which i s  p a r t ia l ly  surrounded by su b stru ctu ra l 
p ro te in  or lip o p r o te in  u n its  (1 1 5 ) . The c a lcu la ted  p ro te in  coverage
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o f human serum OLP (1 5 .7  A squared) a llow s the l ip id s  to  be packed in
o
c o rr ec t  proportions in s id e  a 10 A th ick  s h e l l  o f p ro te in  (5 5 ) .  These 
c a lc u la t io n s , however, assume a p r o la te  e l l ip s o id  shape fo r  QLP.
Because o f the ease  w ith  which the l ip id  and p ro te in  m o ie tie s  
o f serum CLP could be separated  by treatm ent w ith  organic s o lv e n ts ,  
the l ip id -p r o te in  a s so c ia t io n  was thought to  in v o lv e , among o th ers , 
London-van der Waals' d isp ers io n  fo rce s  (115 ,116 ,117 ) and hydrogen 
bonding. However, the io n ic  groups o f p h osp h o lip id s, the carb oxylate  
groups o f e s te r s  and the hydroxyls o f  c h o le s te r o l could form a n e t ­
work o f organized fo rce s  which in flu en ce  the p r o te in - l ip id  a s so c ia ­
t io n  and co n fig u ra tio n  (5 5 ) . The l ip id  to  l ip id  bonding would not  
y ie ld  a reproducib le macromolecular s tru ctu re  o f CLP (1 1 5 ); th is  
makes Off im portant for  the s o lu b i l iz a t io n  o f l ip id s  and for  m ain tain - 
ance o f CLP stru c tu re .
Behavior o f  Off in  S o lu tio n  
Human and horse Off in  so lu t io n  could be d is so c ia te d  by the 
ad d itio n  o f sodium dodecyl s u lfa t e  in to  sm aller p ro te in  u n its  as shown 
by the change in  the sed im entation  c o e f f i c ie n t  and e le c tr o p h o r e tic  
m o b ility  on agar g e l w ith  no e f f e c t  on i t s  immunologic response or 
l ip id  recombining ca p a c ity .
Shore and Shore (66) a ls o  showed th a t a subunit o f  36,500  
m olecular w eigh t, con ta in in g  one mole am ino-term inal a sp a r tic  a c id  
per 38,000 g p ro te in , was produced by the a d d itio n  o f  sodium dodecyl 
s u lfa t e  to  Off s o lu t io n . The m olecular w eight o f the subunit co rr es­
ponded to  approxim ately h a lf  the v a lu e  reported  by Scanu e t  (60)
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f o r  OP i n  e l e c t r o l y t e  s o l u t i o n .
The QflP subunit r e a sso c ia te d  to  y ie ld  the 'dimer' form upon 
d ia ly s i s  to  remove the sodium dodecyl s u lfa t e  from so lu t io n  by d ia ­
l y s i s .
Human OS formed aggregates in  0 .15  M NaCl and phosphate b u ffer  
a t  pH 7 to  8 which could be d is s o c ia te d  by in crea se  in  pH or a d d itio n  
o f urea w ith  no change in  the in  v iv o  or in  v it r o  recom bining ca p acity  
o f CtP towards serum l ip id s  (1 1 8 ) .
P relim inary l i g h t  s c a t te r in g  measurements performed by Dr.
J . K ratoh vil (119) on the same human CKP, prepared in  th is  lab ora tory , 
in  the con cen tra tio n  range from 7 .7  x 15"^ to  4 .7  x 1 0 g per m l, in  
phosphate b u ffer  so lu t io n  (u 0 .1 ,  pH 8 ) ,  in d ica ted  th a t  p o lym erization  
o f  CKP was a con cen tra tion  dependent p ro cess . The a d d itio n  o f  sodium 
dodecyl s u lfa t e  caused a decrease in  the observed t u r b id i t ie s ,  in  
agreement w ith  the low ering o f  the sed im entation  c o e f f i c i e n t s .
D is so c ia t io n -a s s o c ia t io n  phenomena s im ila r  to  th ose o f  QP were 
r e c e n t ly  d escrib ed  for  m itochondria l s tr u c tu r a l p ro te in  (121) and for  
se v e r a l enzyme p ro te in s  (1 2 0 ) ,
The u se  o f  d etergen ts and so lv e n ts  to  d isru p t the in te r -p r o -  
te in  bonds in fe r r e d  th a t m ainly hydrophobic and hydrogen bonds con­
tr ib u ted  to  the s t a b i l i t y  o f the p ro te in  agg reg a tes. E le c t r o s ta t ic  
fo r c e s ,  London fo rce s  or s t a b i l iz a t io n  by e le c tr o n  d e lo c a liz a t io n  
a cross hydrogen bonds would probably be le s s  prominent co n tr ib u to rs  
to  the s t a b i l i t y  o f  the OP s tr u c tu r e (s )  (1 1 7 ).
The m itochondria l lip o p r o te in  might be c lo s e ly  r e la te d  to  OP. 
I t  should be f e a s ib le  for  the OP, which m ight be sy n th es ized  in  the
60
m icros (m es, to  tr a v e l to  the m itochondria, p ick  up l ip id s  frcm m ito­
chondria l l ip o p r o te in s , and then lea v e  the c e l l  as (X -lipoprotein  mole­
c u le s  ( 8 1 ,8 2 ) .  This scheme would a s s ig n  OF another fu n ctio n , namely, 
in tr a c e l lu la r  l ip id  tran sp ort.
The presence o f  CKP aggregates v it r o  would in d ic a te  th a t the  
p ro te in  m olecu les assume the most thermodynamically favored configura­
t io n  under a p a r tic u la r  s e t  o f  experim ental c o n d it io n s . I t  was a ls o  
sp ecu la ted  th a t OJP polym erization  could  occur jj i  v iv o  (118) to  exp la in  
the two m olecular w eights rep orted , i . e . ,  175,000 and 375,000 (5 4 ) .  
However, i t  would be d i f f i c u l t  to  say , as poin ted  out by Shore and 
Shore (6 6 ) ,  whether CÜP chains in te r a c t  d ir e c t ly  or whether they were 
jo in ed  togeth er  by l ip id  'b r id g es' in to  QLP m olecu les.
The d is s o c ia t io n  o f enzymes in to  subunits (120) r e s u l t  in  lo s s  
o f enzym atic a c t iv i t y  which was regained  upon r e a s so c ia t io n  o f the 
subunits in to  th e ir  n a tiv e  form, which su ggests  th a t the h igh  degree 
o f fo ld in g  i s  n ecessary  for the enzymic su b stra te  in te r a c t io n .
The recom bination o f QP w ith  serum l ip id s  in  the presence o f  
urea, sodium dodecyl s u lfa t e ,  and s u c c in ic  anhydride may in d ic a te  th a t  
a higher degree o f  fo ld in g  o f  the QP m olecule could n o t be the major 
s ta b i l iz in g  fa c to r  in  the p ro te in  l i p i d  a s so c ia t io n  and th a t su cc in y la ­
t io n  (122) o f  the E -NHg"*" group o f  ly s in e  does not in h ib it  reccm bination  
o f QP w ith  serum l ip id s .
Human and Horse Serum Phospholip ids  
The d is tr ib u t io n  o f sphingom yelin in  horse serum phospholip id  
was lower than in  human serum or human serum QLP. Ordinary horse
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d ie t ,  low in  c h o le s te r o l,  might decrease sphingom yelin d is tr ib u t io n ,  
but no data on horses could be obtained in  the l i t e r a tu r e  to  th a t  
e f f e c t .  In r a b b its . Van Handel (123) showed th a t c h o le s te r o l feed in g , 
but n ot soy bean phosphatides, ra ise d  t o t a l  plasma phosphatide le v e l  
and in creased  sphingom yelin d is tr ib u t io n .
In human, serum and low d en s ity  lip o p r o te in s  were r ich er  in  
sphingom yelin than OLP (5 7 ,5 8 ) ,  The presence o f tw o-th ird s to  th ree -  
fourths o f  the horse serum l ip id s  as QLP could  be an a d d itio n a l fa c to r  
which r e s u lt s  in  the decreased sphingom yelin d is tr ib u t io n .
■ Human Serum VHDLP
The q u a n tita tiv e  l ip id s  and phosphatide an a lyses o f  human 
serum VHDLP were in  agreement w ith  those reported  by P h i l l ip s  (89) 
showing ly s o le c i t h in  as the p r in c ip a l phosphatide.
Evidence which may su g g est th a t the p ro te in  m oiety o f  QLP and
VHDLP a r e  t h e  sam e w as o b t a i n e d  b y  u l t r a c e n t r i f u g a l  a n d  e l e c t r o p h o r e t i c
analyses o f  QP-I^^^ or QLP-I^^^, and by the id e n t i f ic a t io n  o f QP-I^^^
in  the 1.210 g per ml in fra n a ta n t fr a c t io n  o f serum from su b jec ts  who 
131rece ived  QP-I in tra v en o u sly . F in a l p roof, however, would aw ait 
i s o la t io n  and c h a ra c te r iza tio n  o f the p ro te in  m oiety o f VHDLP.
The presence o f h igh amounts o f  ly s o le c i t h in  in  VHDLP would 
su ggest th a t e l e c t r o s t a t ic  fo rces  could be in volved  to  a g rea t degree 
as w e ll  as van dar Waals' fo rces  in  m aintain ing the stru ctu re  of 
VHDLP.
The d iffe r e n c e  in  e le c tr o p h o r e tic  m o b ility  o f QLP and VHDLP 
on sta rch  g e l  was due to  the d if fe r e n c e  in  the amount o f n eu tra l
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l ip id s  bound, which a f f e c t  the d if fu s io n  o f  the lip o p r o te in  due to  
change in  m olecular s i z e .
Metabolism o f Human Serum CüLP
The tim e course o f the plasma r a d io a c t iv ity  fo llo w in g  the in ­
je c t io n  o f or in  normal su b je c ts  in d ica ted  th a t the
h a lf-t im e s  in  both in sta n ces  were s im ila r , averaging 3 .5  days. This 
was in  agreement w ith  the r e s u lt s  o f  G it l in  e t  a l .  (6 9 ) , u sing  
in  h ea lth y  a d u lt men. The la t t e r  in v e s t ig a to r s  noted th a t the h a l f -  
tim es were s im ila r  whether obtained from measurements o f r a d io a c t iv ity  
in  whole body or in  plasma and th a t the in je c te d  traveled  in
the plasma along w ith  the lip o p ro te in s  o f  d e n s ity  g rea ter  than 1.063  
g per m l, a fin d in g  w ith  which our data were in  agreement.
The sh orter  h a lf-t im e  o f 0£P-I^^^ in  the hyperlipem ic and hyper-  
chy1omicronemic p a t ie n ts  than in  the h yp erch o lestero lem ic  and normal 
su b jec ts  would su ggest a more rapid  QLP turnover in  the former in d i­
v id u a ls . This might be r e la te d  to  a sm aller QLP p oo l s iz e  in  these  
su b jec ts  in  view  o f the reduced amounts o f QLP l ip id s  in  th e ir  serum 
(9 0 ,9 1 ) .
The g rea ter  r a d io a c t iv ity  noted in  the d <1.006  lip o p r o te in  
fr a c t io n  in  the hyperchylomicronemic s ib l in g s  a f t e r  the in g e s t io n  o f  
a f a t t y  meal probably i s  r e la te d  to  the f a c t  th a t  the excess  low 
d en sity  l ip id s  in  th ese  su b jec ts  were in  the form o f chylomicrons 
(S f >13 ,000) as demonstrated by G ustafson e t  (123) in  th is  la b ­
oratory .
I t  was mentioned e a r l ie r  th a t QP was capable o f recom bination
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w ith  chylom icrons in  v i t r o . According to  r e s u lt s  o f  Shore (5 3 ) ,
Aviean e t  a l .  (6 4 ) ,  R odbell and Fredrickson (7 1 ,7 2 ) ,  Furman e t  a l .
(7 3 ) , and Hofmann (7 4 ) ,  one o f the p ro te in s  p resen t in  the chylom icrons 
p o sse sse s  c h a r a c te r is t ic s  o f  the OCP.
The r e d is tr ib u t io n  o f r a d io a c t iv ity ,  p a r t ic u la r ly  in  su b jec t
H.H., fo llo w in g  heparin , would su g g est th a t  the postheparin  lip o p r o te in  
l ip a s e  e f f e c te d  rap id  h y d ro ly sis  o f  chylom icron tr ig ly c e r id e s  and d is ­
rupted the OtP-chylomicron a s so c ia t io n .
L ip id u ria  and C t-lipoproteinuria  in  the 
N ephrotic Syndrome
L ip id u ria  occurs in  a v a r ie ty  o f  d ise a se s  (125 ,126) th a t a f f e c t  
the kidneys and lead  to  album inuria. In nephrotic  syndrome, urinary  
l ip id s  are ex creted  e ith e r  in  the form o f  a n iso tro p ic  bod ies c o n s is t ­
ing m ainly o f  c h o le s te r o l  e s te r s  and some fr e e  c h o le s te r o l (127) or in
a s o lu b il iz e d  form, presumably bound to  a p r o te in . This s o lu b il iz e d
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l i p i d  i s  c a p a b l e  o f  b i n d i n g  w i t h  O JP-I v i t r o  t o  fo rm  Q L P -I
G it l in  _et a l .  (69) has found protein-bound 1^31 u rin e  o f
*1 o i
n ep h rotic  p a t ie n ts  fo llo w in g  the in je c t io n  o f  OLP-I , a f in d in g  th a t  
i s  in  agreement w ith  our r e s u l t s .  We a ls o  fin d  th a t a fourth  o f  the 
protein-bound l^ ^ l p resen t as QLP, the remaining th ree -fo u rth s  o f  
the r a d io a c t iv ity  remains in  the 1 .210 g per ml in fra n a ta n t.
S tu d ies  by Gerard (1 2 8 ), Smetana and Johnson (129) on open 
nephron o f Salamander in d ic a te  the occurrence o f double a th e r o c y to s is  
(reab sorp tion  o f p ro te in  and c h o le s te r o l in  d if fe r e n t  s e c t io n s  o f  the  
open nephron). In n ep h rotic  p a t ie n ts ,  only OfljP could pass through but 
n ot low d e n s ity  lip o p r o te in s  (6 9 ) . The QLP are e ith e r  p a r t ia l ly  de-
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l ip ld lz e d  during the process o f  f i l t r a t io n  through the glomerulus or, 
as cu rren tly  b e lie v e d , p a r t ia l ly  d e lip id iz e d  in  the proximal tubule  
w ith  p r e fe r e n t ia l removal o f  c h o le s te r o l e s te r s  (1 3 0 ) . The la t t e r  pre­
c ip i t a t e  in tr a c e l lu la r ly  in  the proximal tu b ules lead ing  to  death and 
desquamation and appears as "M altese-cross"  b od ies or aval bod ies which 
are a n iso tr o p ic .
Our r e s u lt s  support the h yp oth esis  th a t lip o p ro te in u r ia  occurs 
in  the nephrotic  syndrome, but the cause o f  the l ip o id  changes in  the 
proxim al tubule remains a m atter for  sp ecu la tio n .
CHAPTER V
SUMMARY
The p ro te in  m oiety (0!P) o f h ig h ly  p u r if ie d  human serum CK- 
lip o p r o te in  (CKLP, d en sity  1 .0 6 3 -1 .2 1 0  g per ml) has been is o la te d  and 
i t s  homogeneity e s ta b lish e d  by u ltr a c e n tr ifu g a l,  e le c tr o p h o r e t ic , end- 
group and b io lo g ic a l  a n a ly ses . The purpose o f th is  d is s e r ta t io n  has 
been to  compare the chem ical, ph ysico -ch em ica l, and b io lo g ic a l  charac­
t e r i s t i c s  o f  normal human and horse serum CtLP and 0!P, to  id e n t ify  the 
p ro te in  m oiety o f  very h igh d en s ity  lip o p ro te in s  (VHDLP, d en sity  
>1.210 g per ml) and to  in v e s t ig a te  the metabolism o f rad io iod in a ted  
human QLP and QP in  normal and hyperlip idém ie su b je c ts .
Human and horse sera , analyzed for l ip id s  and lip o p r o te in s ,  
were su bjected  to  u ltr a c e n tr ifu g a tio n  a t  105,000 x g for  22 hours in  
a so lv e n t  d en sity  o f  1.063 g per ml to  remove lower d en sity  lip o p ro ­
t e in s .  The so lv e n t d en sity  was ad justed  to  1.210 g per ml and u ltr a ­
c e n tr ifu g a tio n  repeated  to  ob tain  QLP. The la t t e r  was washed 2 to  3 
tim es w ith  NaCl-KBr so lu tio n  o f d en s ity  1.210 g per ml and subjected  
to  u ltr a c e n tr ifu g a tio n  a fte r  each washing to  remove tra ces  o f  albumin. 
Subsequently, the QLP was d e lip id iz e d  a t  -30°C w ith  r e d i s t i l l e d  ethanol 
and d ie th y l e th er .
Horse serum contained le s s  t o t a l  l ip id s ,  grea ter  proportions
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of OŒjP and a lower percentage d is tr ib u t io n  o f sphingom yelin and phos- 
p h o in o s ito l than human serum. Human and horse serum OUP and CCS d is ­
so lved  in  e le c t r o ly t e  so lu t io n s  appeared as s in g le  boundaries during  
a n a ly t ic a l u ltr a c e n tr ifu g a t io n  and s in g le  p ro te in  bands a f te r  e le c t r o ­
p h oresis on agar or starch  g e l .  The sed im entation  r a te s  and e le c t r o ­
p h oretic  m o b ili t ie s  o f human serum QLP and QP were cmnparable w ith  
those o f horse serum QLP and QP. Human and horse serum QP had the  
same N -term inal amino acid  (a s p a r t ic  ac id ) and C -term inal amino acid  
(th r e o n in e ). Adding sodium dodecyl s u lfa t e  to  l ip id - f r e e  QP, but not 
QLP, produced d is s o c ia t io n  in to  a subun it whose r e a s s o c ia t io n  could  be 
obtained by d ia ly s i s .  In v i t r o  s tu d ie s  showed rad io iod in a ted  human 
and horse QP to  be undenatured and capable o f recmnbining w ith  serum 
l ip id s  in  e le c t r o ly t e  s o lu t io n s , urea , sodium dodecyl s u lfa te  or s u c c i­
n ic  anhydride. Human and horse serum QP were immunochemically d i s t in c t  
and had d if f e r e n t  amino acid  re s id u es  and peptide p attern s fo llo w in g  
h y d ro ly s is  w ith  chymotrypsin and/or tr y p s in . Human serum QP d isso lv e d  
in  0 .15  M NaCl, phosphate or b a rb itu ra te  b u ffer  so lu tio n s  formed aggre­
gates which were d is so c ia te d  by in crea sin g  the pH of adding urea.
I t  was concluded th a t horse serum QP has p h ysico-ch em ica l and 
b io lo g ic a l  c h a r a c te r is t ic s  s u f f i c i e n t ly  s im ila r  to  those o f human serum 
QP to  perm it i t s  use in  studying th e recombining ca p acity  o f QP w ith  
l ip id s .
S tu d ies on human serum VHDLP other than lipalbum in were per- 
131formed using QP-I and starch  g e l  e le c tr o p h o r e s is  and in d ica ted  th a t  
the p ro te in  m o ie tie s  o f QLP and VHDLP are probably id e n t ic a l .
An Q -lip o p ro te in u r ia  was demonstrated in  a p a t ie n t  w ith  the
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131nephrotic  syndrome fo llo w in g  the In je c t io n  o f  0£LP-I
The h a lf-t im e s  o f h ig h ly  p u r if ie d  OLP-I^^^ or OP-I^^^ adm inis­
tered  In travenously  to  normal su b jec ts  were s im ila r , averaging 3 .5
131days. The h a lf - t im e  o f 0£P-I was normal In one h yp erch o lestero lem ic  
su b je c t , 1 ,7  and 1 .9  days In two s ib l in g s  w ith  hyperchylom lcronem la, 
and 2 .5  and 2 .7  days In two p a t ie n ts  w ith  e s s e n t ia l  hyperlipem ia. The 
l ip o p r o te in  fr a c t io n  o f d en s ity  > 1.063 g per ml contained  over 94 per 
cen t o f  the In jec ted  r a d io a c t iv ity  In s tu d ie s  during fa s t in g  on a l l  
su b jec ts  excep t two hyperchylomlcronemic s ib l in g s  In whom an Increased  
r a d io a c t iv ity  was observed In the chylom icron fr a c t io n  (d e n sity  <1.006  
g per m l) . The marked a ccen tu ation  o f chylom icron r a d io a c t iv ity ,  ob­
ta ined  in  one o f  the s ib l in g s  fo llo w in g  a fa t ty  meal was p a r t ia l ly  r e ­
v e r s ib le  by In je c t in g  heparin , which stim u la tes  lip o p r o te in  lip a s e  In 
v iv o .
These observations su g g est  th a t (1 ) OP-I^^^ catabolism  Is  a c c e l­
erated  In hyperlipem ia and th a t  (2 ) In hyperchylomlcronemla an a s s o c ia ­
t io n  of chylom icrons w ith  OP occurs ^  v iv o .
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